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The History of Percutaneous Vertebroplasty 
Percutaneous VertebroPlasty (PVP) involves lhe percutaneous injection ofliquid 
bone cement, usually PolyMethylMethAcrylate (PMMA) and an opaciner (barium 
or zirconium oxide) into the inter-trabecular marrow space of a vertebral body. 
Vertebroplasty was initially developed to be used in combination with 
an open surgical procedure to fill large voids as a result of tumour resection. In 
1984, Galibert and Deramond performed the first ever documented PVP at the 
University Hospital of Amiens, France. 1 The procedure was used in a patient 
with severe cervical pain, due to a large vertebral haemangioma encompassing 
the entire C2 vertebral body. A 15-gauge needle was inserted and acrylic cement 
was injected into the C2 vertebral body via a n anterolateral approac h. This case, 
as published in 1987, reports complete pain relief in this patient. 1 
A paper in the American Journal of Neuroradiology in November 1997,2 describing 
a trial from the University of Virginia, which comprised 29 patients followed 
over a period of three-years, with promising outcomes of PVP in treatment of 
Osteoporotic Vertebral Compression Fractures (OVCFs), prompted a sudden 
and major increase in the number of PVP procedures being performed. 
Next to the "traditional" PVP, a comparable procedure encompassing PVP 
in combination with an inflatable balloon tamp (often referred to as kyphoplasty 
(KP)), arose in the early 1990s and shows comparable clinical outcomes.3 The 
evidence for performing kyphoplasty is however beyond the scope of this thesis 
and therefore will not be discussed. 
Percutaneous Vertebroplasty: Performing the Procedure 
PVP can be performed in multiple ways. In some institutions, t he procedure 
is performed under general anaesthesia using a single C-arm in the operating 
room. In our institution however, the procedure is performed under conscious 
sedation using bi-plane fluoroscopy in a radiological intervention suite. Bellow 
the procedure, as performed in our institution (Leiden University Medical 
Center), is briefly described. 
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The patien t is admitted at the day-care department and 30 minutes after oral 
pain medication (Symoron 5mg and Paracetamol lOOOmg), transferred to the 
radiology department. The patient is placed in prone position on a standardized 
cushion, in such a way that the regions caudally and cranially from the fractured 
vertebra(e) are supported. The patient is prepared and draped in a sterile fas hion. 
Conscious sedation is administered using injectable Fentanyl and Midazolam 11 
(doses depending on weight and procedure duration). During the procedure, 
saturation, blood pressure and heart rate are continuously monitored. Using Bi-
plane fluoroscopy (Figure 1), the fractured level is identified. 
Figure 1. Bi-plane ftuoroscopy set-up. Important advantage of this system is the pos-
sibil ity of direct manipulation of the position of the x-ray tubes by the specialist per-
forming the intervention usi ng the sterile dt·essed control panel. 
High quality fl uoroscopy is mandatory in order to safely perform PVP. First the 
lateral X-ray tube is positioned in such a way that the caudal pedicle arches 
are superimposed and the upper and lower endplate will project as parallel as 
possible on the fluoroscopy image (depending on the grade of vertebral collapse) 
(Figure 2) . 
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Figure 2. S uperimposition of the pedicles (red lines) a nd parallel projection of the 
endplates (blue lines). 
Next, in antero-posterior (AP) direction, the spinal processus are projected in the 
centre of the vertebral body and the pedicles should project over the upper third 
of the vertebral body. The projection of the "pedicle ring'' resu lts from projection 
of the isthmus of the pedicle (Figure 3). 
Figure 3. AP projection or the vertebral body (left) , r ed circle : projection of the is th-
mus of the pedicle at the Auoroscopy image. Projection of the vertebral body (right), red 
circle : projection of the isthmus of the pedicle. 
Local anaesthesia is achieved by injection of Lidocaine 1%. The position of the 
thi n needle used for lidocaine injection determines the direction of the needle 
tract during fluoroscopy. This tract will be used for introd uction of the large 
beveled PVP needle. Thus optimal introduction through the soft-tissues, without 
repeated placement of the large diameter (lOG) PVP needle can be obtained. The 
preferred entrance is at ten-o-clock for the left pedicle, and two-o-clock for the 
right pedicle at the cranio-lateral border of the pedicle. 
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Under biplane fluoroscopy guidance and using a small mallet, one (preferred) 
or two needles are gently introduced into the vertebral body through a trans- or 
extra-pedicular route (depending on the level to be treated). 
The trans-pedicular route is the easiest and safest route to the vertebral 
body in the lumbar spine. During the insertion of the needle into the vertebral 
body, the cortex of the pedicle surrounds the needle. However due to the position 
and angulation of the pedicles of the thoracic vertebral body and due to the fact 
that these (higher) thoracic vertebral bodies have a more pronounced apex, a 
trans-pedicular route is not advised for the (higher) thoracic vertebras. To access 
the (higher) thoracic spine, usually the extra-pedicular approach is used. For 
extra-pedicular approach the needle is inserted between the lateral margin of 
the pedicle of the thoracic vertebrae and the rib head. 
During insertion of the needle, the beveled tip can be used to gain easy 
access to the pedicle by pointing the bevel laterally. When the needle has 
penetrated into the pedicle, prevention of perforation of the medial pedicle wall 
can be obtained by rotating the beveled side of the needle 180° to the medial 
pedicle wall (Figure 4). 
Figure 4. The beveled needle tip design facilitates easy and safe access to the verte-
bral body without penetration of the medial pedicle wall. 
When lateral fluoroscopy shows that the tip of the needle has passed beyond 
50% of the length of the pedicle, and PA projection shows a position of the needle 
lateral to the medial pedicle wall, a safe entrance into the vertebral body has 
been achieved. 
At our institution, vertebral body bone biopsy and vertebroplasty are 
performed in one session using the following technique: the biopsy needle is 
inserted through the vertebroplasty needle just after penetration of the vertebral 
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body. The biopsy needle is withdrawn and the vertebropiasty needle is advanced 
through the same needle tract (see also, Chapter 3 of this thesis). The preferred 
position of the needle is just lateral to the middle of the anterior one third of the 
vertebral body. If this position cannot be achieved, a second needle can be inserted 
through the contra-lateral pedicle. However placement of a second needle can 
14 also be done at a later stage during the procedure in case of inadequate cement 
interdigitation through the first needle. 
The PMMA cement is prepared and transferred to an injector. The air is 
eliminated from the system. After 2-4 minutes after the start of cement mixing 
(depending on the viscosity of the cement and on the room temperature), the 
cement has reached its proper viscosity (toothpaste-like), and is ready to be 
injected. The cement is than injected slowly and carefully under constant bi-
plane fluoroscopic imaging in order to achieve good filling of the intertrabecular 
space of the vertebral body and thus a minimal chance of major cement. 
The injector is disconnected from the needle. Twelve to fourteen minutes 
after mixing, the needle is twisted to separate the tip from the cement. Then 
the needle(s) is (are) removed from the vertebral body. A post-procedural CT-
scan is performed and the patient is placed in bed for transport to the ward . 
The post-procedural hospital stay is a minimum of 3 hours. Fast reactivation of 
the patient is started after the effect of the fentanyl and midazolam has ended, 
additional bed rest is not mandatory. When the overall clinical condition permits, 
the patient is discharged. 
The Indications for Percutaneous Vertebroplasty 
Although vertebroplasty was first used in spina l tumour surgery, the spectrum 
of indications for performing PVP has been increased since then. The procedure 
is also used for painful pathological compression fractures of other aetiologies, 
like trauma, aggressive vertebral haemangioma (Figure 5), multiple myeloma 
(Figure 6) or bone metastasis.4·8 PVP can offer mechanical stability to vertebral 
bodies, which are weakened by tumour invasion, and prevent further bone 
destruction when bone cement is injected between the trabeculae of the remaining 
unaffected bone. 
Patients with disseminated disease and spinal metastasis and patients 
with primary vertebral malignant disease, who are non eligible candidates for 
extensive open surgery due to a combination of eo-morbidity caused by malignant 
disease itself or due to (chemo)therapy, but are su itable candidates for a minimal 
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invasive procedure like PVP. Furthermore, the fact that PVP is performed in 
day-care a nd has a low morbidity rate and a quick potential pain relief, makes it 
an acceptable investment of time for patients with a short life expectancy. 
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Figure 5. Painful pencling vertebral collapse due to an aggressive haemangioma 
treated with PVP. From left to righ t: sagittal and axial eT-reconstruction both showing 
the specific trabecular destruction leading to a typical cement filling pattern as seen at 
a 3D eT-reconstruction (far right). 
Figure 6. Vertebral destruction due to multiple myeloma, treated with PVP. From 
left to right: Sagittal eT-reconstruction showing extensive destruction of Thll and L2. 
Sagittal reconstruction T2 MRI showing BME, most pronounced at Thll and L2. Post-
procedural 3D e T-reconstruction. 
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Due to its high incidence, compared to the above-mentioned indications, a 
painful compression fracture due to osteoporosis is the most common indication 
for PVP. The indication triad for PVP in OVCFs at our institution consists of I) 
incapacitating pain at the fractured level, with focal point tenderness, which 
increases when pressure is applied to the spinous process of the fractured 
16 vertebra, 10• 11 Il) unresponsiveness to at least 6-8 weeks of conservative trea tment9 
and Ill) Bone Marrow Edema (BME) in the fractured vertebral body diagnosed 
at MR Imaging (see also, Chapter 2 of this thesis).l2· 14 (Figure 7) 
Figure 7. Example of a patient with multiple OVCFs as seen on the plain radiograph 
(A) . On MR Imaging only one vertebra shows intravertebral BME (B). Lateral 
fluoroscopy images (C) and (D) show insertion of the needle and injection of the 
bone cement respectively. AP fluoroscopy image of cement injection (E) and 3D eT-
reconstruction of the treated vertebra with cement (depicted in red). 
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Osteoporotic Vertebral Compression Fractures 
The Osteoporotic Vertebral Compression Fracture (OVCF) is, with an estimated 
prevalence in the Netherlands of 18% for men and 22% for women above the age 
of 55 years, the most common complication of osteoporosis. 15·18 
In the year 2000, Dutch hospitals registered over 40.000 new vertebral 
fractures due to primary or secondary osteoporosis and with the ageing population 
it is expected that this num ber will increase throughout the upcoming years. 19 
The Dutch population is expected to have the highest absolute increase of the 
number of OVCFs in the twenty-first century, compared to the other members of 
the European Union, 19 
Two thirds of the OVCFs have no clinical symptoms, they are "silent" 
fractures and are asymptomatic and as such there is no need for direct medical 
attention other than screening and treatment for osteoporosis in order to reduce 
the chance of new fractures.20· 21 
In the group of patient with clinical symptoms due to an OVCF (one-third 
of all patients with a OVCF), pain is the most striking feature of the fracture. 
Next to pain, diminished mobilization is caused by progressive kyphosis, which 
in turn gives a decrease in lung capacity, with a subsequent decreased physical 
condition, which eventually results in an increase of bone loss, which is again the 
first step in a vicious circle leading to more OVCFs.22• 23 
Treatment of Painful Osteoporotic Vertebral Compression 
Fractures 
l n80-85% of the acute symptomatic patients, pain will disappearwithconserva tive 
Lreatment within 6-8 weeks after initiation of treatment. 24 ·26 In the Netherlands, 
conservative treatment is therefore the preferred initial treatment in patients 
with an acute symptomatic OVCF without neurological symptoms. Conservative 
therapy involves a short period of bed rest (for a few days) and administration 
of oral analgesics and, optionally, short-term use of a thoraco-lumbar brace in 
order to achieve red uction of pain.27 In case of neurological symptoms due to 
spinal stenosis, an open decompression combined with posterior stabilisation 
using pedicle screws, and vertebroplasty of the anterior vertebral column can be 
the treatment of choice. 
Patients without neurological deficit, and no reduction of pain after 8 weeks 
of conservative treatment have a high chance of ending in a chronic circle of 
repeated pain attacks, with intermittent temporary pain relieve of a period for 
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up to two years.24 For this group constituting 15-20% of the symptomatic OVCFs, 
i.e. patients with fractures refractive to conservative treatmen t, PVP can, after a 
careful workup, be the treatment of choice. 
Outcome in Osteoporotic Vertebral Compression Fractures 
18 Because of its reported fast analgesic effects, high effectiveness, low complication 
rate and relatively low cost, PVP has emerged as a widely used minimal i nvasive 
treatment of painful OVCFs over the past two decades.28 The effect of PVP for 
OVCFs on pain is reported to be fast and reaches a plateau phase within a few 
days after the procedure.29 After this period, the pain-scores do not change (see 
also, Chapter 4 of this thesis).3°·33 
A meta-analysis of 60 studies reporting pre- and post-operative Visual 
Analogue Scale (V AS) scores (in which 10 represents excruciating pain) showed 
a mean pre-operative VAS of 8.36 (SD±0.78) and a mean post-operative VAS of 
2.86 (SD:t1.09). A mean and significant change in pain of 5.68 (SD:tl.24)) on the 
VAS scale was found after PVP.3 
Unfortunately, severe methodologi.cal problems exist in published studies 
so far. Most studies focus only on (often short term) pain outcome and do not 
report the use of any type of validated questionnaires reporting general Quality 
of Life, making it impossible to compare the PVP procedure with other (non- or 
minimal-invaF;ivP.) pror.P.rlurP.R (F;P.P. also, Chapter 4 of this thesis). Furt.hP.rmorP., 
the majority of papers describe populations that are a case mix of"acute" (fracture 
age < 8 weeks) and '1ong-standing" (fracture age >8 weeks) OVCFs. The former 
having frequently a favourable natural course (there is a high chance that an 
acute OVCF will heal even without treatment). 
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Complications in Osteoporotic Vertebral Compression 
Fractures 
The rate of clinically relevant complications after PVP for OVCFs is low. 
Complication rates reported range between 1.6% and 2.8%.34 Most of these 
clinically relevant complications are due to leakage of bone cement (see also, 
Chapter 5 & 6 of this thesis) . Severe complications are rare and occur mainly in 
cases of high-volume cement leakage and are mainly reported in case reports.35·38 
Leakage of cement into the neural foramen or spinal canal can cause neurological 
injury.39 Procedure related complications unrelated to cement leakage include; 
misplacement of the needle, rib fractures, pneumothorax, fracture of spinous 
process or pedicle, subcutaneous paravertebral haematoma and infection.32• 40•45 
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Aim and Outline of this Thesis 
This thesis focuses on indications for and the clinical outcome of PVP for the 
treatment of long-standing OVCFs (i.e. after more than 8 weeks after onset of 
symptoms). Secondly, emphasis is made on the value of vertebral body biopsy 
20 during the vertebroplasty procedure in order to aid in early diagnosis of unexpected 
conditions. Thirdly, in line with the worldwide emerging registration and control 
of medical implants, emphasis is put on the need for careful registration of 
cement leakages, since these count for the largest number of clinically relevant 
complications of the vertebroplasty procedure. 
Chapter Outline of this Thesis 
The correlation between the amount of BME and the clinical outcome (pain) 
of PVP is discussed in Chapter 2. In Chapter 3, the outcome of a routine 
bone biopsy during PVP in treatment of "osteoporotic'' vertebral fractures, was 
studied. A prospective follow-up study on the clinical outcome (Quality of Life as 
measured with the SF 36) up to 36 months after PVP for long-standing OVCFs, 
is discussed in Chapter 4. In Chapter 5, the clinical outcome ofPVP in patients 
wiLh long-sLanding OVCFs, LreaLed wiLh eiLher low or medium viscosiLy PMMA 
bone cement, was evaluated in a prospective comparative follow-up study. In 
Chapter 6, a new system for Evaluation and registration of eXtra vertebral 
cement leakage based on Anatomy and Volume of the leakage using CT-scan 
analysis (the EXACT classification system), is proposed. Finally, in Chapter 7 a 
review of the scientific evidence for PVP is presented. 
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The Amount of Bone Marrow Edema Does 
Not Predict the Outcome in Single Level 
Percutaneous Vertebroplasty For Painful 
Osteoporotic Compression Fractures 
Submitted 
Abstract 
In tills study the influence of the pre-procedural intravertebral Bone 
Marrow Edema (BME) on post-operative pain relief in patients treated with 
single level Percutaneous VertebroPlasty (PVP) for non-acute osteoporotic 
28 vertebral compression fractures (OVCF) is investigated. Twenty-five 
patients with single level, BME containing OVCFs were included. BME 
volume and the percentage of the vertebral body filled with BME was 
volumetrically analyzed. 
The mean BME volume was 11.4 mL (SD 8.2, range 2.6 - 29.3), 
which corresponded to a mean percentage of vertebral body volume of 46.0% 
(SD 19.5, range 10.0- 7l .4). During a 1-year follow-up, pain intensity was 
documented before PVP and 1, 4, 12 and 52 weeks after PVP. 
A good clinical response to the PVP procedure was seen in all 
patients: pain decreased from 7.6 (SD 1.3) points before PVP to 5.3 (SD 
2.6), 5.3 (SD 2.6), 3.7 (SD 2.3) and 2.9 (SD 2.2) points at 1, 4, 12 and 52 
weeks follow-up. No association between the pain score and the percentage, 
ranging from 10%-70% BME, was found. The percentage of the vertebral 
body filled with BME on pre-proceduralMRI does not predict the magnitude 
of pain reduction when performing PVP in single level non-acute OVCF. 
INDICAT.ON 
Introduction 
Percutaneous vertebroplasty, a procedure in which liquid bone cement is 
percutaneously injected into painful osteoporotic compressed vertebral bodies, is 
thought to relieve pain due to the stabilizing effect of the cured bone cement after 
polymerization. The precise mechanism (mechanical, or chemical) is still not 29 
completely known, but it has been shown that the bone cement halts movement 
within the fractured vertebral body and thus prevents further collapse. 1 Although 
recently some debate exists on the effect of this procedure, analysis of factors 
determining the clinical entity of Osteoporotic Vertebral Compression Fractures 
(OVCF) is of importance to evaluate the effectiveness of PVP.2·3 
Subacute (>2 month old) and chronic (>6 month old) OVCFs are 
fractures which do not respond to at least 8 weeks of conservative treatment 
using analgesics, a short period of bed rest and a corset. Therefore, the indication 
triad for PVP in our institution consists ofl) incapacitating pain at the fractured 
level,unresponsive to conservative treatment\ Il) focal point tenderness, which 
increases when pressure is applied to the spinous process of the fractured 
vertebra5•6; and Ill) Bone Marrow Edema (BME) in the fractured vertebral body 
diagnosed at MR Imaging.H 
In literature, it is stated that, intravertebral BME on MR Imaging is one 
of thfl inrlir.ation r.ritflria for f".rf!at.ing painful OVCFs with PVP. A MR Tmaging 
sequence with fat suppression, usually T2 Short Tau Inversion-Recovery (STIR) 
or Spectral Presaturation with Inversion Recovery (SPIR), leads to images in 
which structures with a high water content show a high signal and thereby 
visualize BME. 
Intravertebral BME is seen in OVCFs that have not fully been healed. 
In these vertebra it is though t that persistent pain is caused by movement 
in unconsolidated (micro)fractures. The cause of persistent BME in chronic 
fractures might be explained by the altered healing cascade in these fractures 
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So far a small number of papers concerning BME in PVP have been published, 
however due to heterogeneous groups (acute vs chronic and multiple level vs 
single level), no conclusions regarding the influence of the volume of BME in 
chronic OVCFs can be made.U-13 Furthermore there is no consensus about the 
percentage of the vertebral body that has to be filled with BME in order to be an 
30 indication for PVP nor on the relation to the clinical results after PVP. 
The goal of our present study was to assess the influence of the pre-
procedural intravertebral BME on the clinical outcome on pain in patients 
treated with PVP for single level non-acute OVCFs. 
INDICAT.ON 
Patients and Methods 
Patients were included from a consecutive series of 217 patients treated with 
PVP for painful OVCFs at our institution between August 2002 en January 
2010. Inclusion criteria for PVP were: (I) An osteoporotic vertebral compression 
fracture including those with a severe compression deformity, ( II) local mid- 31 
line back pain refractory to conservative treatment for at least 8 weeks, (Ill) 
back pain related to the site of the fracture on MR Imaging, (IV) the presence of 
intra vertebral BME in the collapsed vertebral body on MR Imaging T2- weighted 
Short Tau Inversion Recovery (STIR) sequences, and (V) age over 40 years. 
Exclusion criteria were (I) multiple OVCFs with intravertebral BME, 
(II) spinal cord compression or vertebral canal stenosis of >30% of the local canal 
diameter, (III) neurologic deficits, (IV) bleeding disorders, (V) infections related 
to the vertebral column, (VI) inability of the patient to lie in prone position for 
2 hours, (VIT) an American Societ,y of Anesthesiologists-score 2: 4 and (VIII) 
vertebral cleft fract,ures. 
In this study, twenty-five pat,ient,s (4 male, 21 female, mean age of 72.0 
(SD 7.7) years) with a single level, intravertebral BME containing, OVCF with 
a mean time between onset of symptoms and PVP of 5.7 months (SD 2.6), were 
included for a prospective study. 
All p~tiflnt.s undflrwflnt ~ prfl-Opflr~tivfl r~rliogr~ph of thfl spinfl (AP ~ne! 
lateral), a MR lmaging scan using a sequence with fat suppression, T2 Short Tau 
Inversion-Recovery (STIR) of the complete spine to visualize intra vertebral BME 
with sagittal reconstructions using 5-millimeter slice thickness. 
The levels of the treated chronically painful OVCFs were Th5(1), Th6(1), 
Th7(2), Th8(1), Th9(1), Thll(l), Th12(4), Ll(l), L2(6), L3(3), L4(4). A mean of 
:l.5 (SD :l.5) old fractures without signs of intravertebral BME were present, 
mean spinal deformity index was 6.2 (SD 4.9). 14 
The volume of the intravertebral BME was measured by 2 independent 
observers (SPJM, LB) using a visual threshold (Figure 1). Excellent inter-
observer agreement was found for measurement of the intravertebral BME 
volume (I CC 0.98, 95%CI: 0.96- 0.99, p < 0.001). For calculation of the vertebral 
volume and intra-vertebral BME a DICOM viewer (Osirix 3.3, 64 bit, Kagi, 
Berkeley, California) was used. 
INDICAT.ON 
The PVP procedure was performed as a uni-or hi-pedicular method using PMMA 
bone cement as described earlier, and during the PVP procedure in all cases a 
bone biopsy was performed, to rule out other causes than osteoporosis. 15•16 
During a 1-year follow-up all patients recorded a Pain Intensity Numerical 
Rating Scale (PI-NRS) before PVP and at 1, 4, 12 a nd 52 weeks after PVP. Patients 
32 underwent routine spinal radiographs at 6 and 52 weeks and at indication. 
Figure 1. Meastu·ement of intravertebt·aJ BME on 1'2 weighted S'l'IR images (thick-
ness 5 mm) . Examples of BME containing vertebra of two patients. A: 64% and B: 27% 
of the total intravertebral volume is filled with BME. The border of the BME (high 
signal) is depicted by the red line. 
Statistical analysis 
The inter-observer agreement of the volu me of in tra vertebral BME was assessed 
by calculation of the Intraclass Correlation Coefficient (I CC) (two-way mixed) . 
Measured values are reported as mean with Standard Deviation (SD) 
and range, estimates are reported as mean and 95% Confidence Interval (Cl). 
Patient -reported pain scores were a nalyzed using a linear mixed-model 
analysis, which takes the correlation between the repeated measurements within 
patients into account. Additional covariates in the analysis were patient age and 
gender, time since onset of symptoms, spinal deformity index and the occurrence 
of new OVCFs during follow-up.17 
In all analyses, the model assumptions were assessed. A p -value of less 
tha n 0.05 was considered significant (SPSS statistical software 16.0, SPSS Inc, 
Chicago, IL) . 
INDICAT.ON 
Results 
The mean pre-procedural PI-NRS score for back pain was 7.6 (SD 1.3) points, 
which decreased to 5.3 (SD 2.6), 5.3 (SD 2.6), 3.7 (SD 2.3) and 2.9 (SD 2.2) points 
after respectively one, four, 12 and 52 weeks post-procedurally (p < 0.001)(Figure 
2). Six new OVCFs were noted in 5 patients after a mean of 8.0 months (SD 5. 7) . 33 
Three of these were adjacent fractures, which occurred after 1.3, 1.6 a nd 11.4 
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Figure 2. Mean back pain measured in pain intensity numeric rating scale score 
after one, four, 12 and 52 weeks post-operatively. 
INDICAT.ON 
The mean intravertebral edema volume was 11.4 mL (SD 8.2, range 2.6- 29.3), 
which corresponded to a mean percentage of vertebral body volume of 46.0% (SD 
19.5, range 10.0- 71.4)(Figure 3). 
In multivariate repeated measures analysis, no association was found 
between the volume percentage of BME (in the range of 10%- 70%) and post-
34 procedural back pain (0.04 per 10% vertebral body volume, 95%CI: -0.18-0.26, 
p = 0.711). 
If the volume ofBME was dichotomized in< 50% and ~ 50%, intra vertebral 
volume of BME (mean difference 0.27, 95%CI: -0.7 4- 1.28, p = 0.581) or in <33% 
and~ 33% volume of intra vertebral BME, no significant effect could be identified 
(mean difference 0.27, 95%CI: -0.74 - 1 .28, p = 0.581 and 0.33, 95%CI: -0.61 
- 1.28, p = 0.466) . 
Besides the positive effect of the PVP procedure itself, occurrence of a new 
OVCF during follow-up was consistently the only significant factor associated 
with the post-proced ural outcome in terms of pain score (PI-NRS): occurrence of 
a new OVCF during follow-up was associated with a higher post-procedural pain 
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Figure 3. Shows the intravertebral BME volume (mL, y-axis) vs the intravertebral 
volume of the fractured vertebral body (mL, x-axis) . The diagonal line depicts 100% 
filling with BME. 
INOICAT.ON 
Discussion 
Bone Marrow Edema (BME) due to unhealed (micro) fractures is seen in painful 
chronic osteoporotic vertebral compression fractures (OVCFs). Intravertebral 
BME persists in subacu te and chronic painful OVCFs due to t he altered healing 
cascade of the compression fracture caused by osteoporosis. The healing cascade 
of an OVCF is different compared to the well-organized healing cascade of a 
fractured long bone. The normal healing cascade in fractures oflong bones consists 
of four stages. Resorption of necrotic bone is followed by matrix synthesis, bone 
formation and finally bone remodeling. In OVCFs with intravertebral BME on 
MR Imaging, these stages of bone healing are not seen as separate stages but 
show ovedap. 10 The overlapping stages of the healing cascade seen in vertebral 
bodies containing BME may possibly be due to micro fractures due to slowly 
continuing collapse of the osteoporotic vertebral body. 
In most clinics, intra vertebral BME is one of the criteria for performing 
a PVP procedure. However, no guidelines on percentages of intravertebral 
BME in OVCF exists to be indicative as a threshold value for PVP. Moreover, 
the effect of BME in OVCF has not been quantitatively evaluated and studies 
are usually heterogeneous (multilevel versus single level OVCF). As such, the 
influence of the degree of intravertebral BME on the outcome of PVP remains 
unr.lP.ar. I n r.ont.rast. t.o this lar.k of P.virlP.nr.P., physir.ians oft.P.n fflfll that. a totally 
white vertebral body (100% vertebral body volume of intravertebral BME) at MR 
Imaging will have an excellent clinical outcome after PVP. 
A review of the li terature on int,ravertebral BME as (part of) the indication 
for PVP shows conflicting evidence. In 2005, Brown et al. showed no correlation 
between the outcome ofPVP in chronic OVCFs and the presence ofintravertebral 
BME at MR Imaging. However, they analysed BME in a dichotomous way (no 
BME (0%) vs. presence of any BME), patients had 1 to 5 OVCFs, and no pain 
score was used.U Contrary to this, 50-100% of intravertebral BME in OVCFs 
showed good pain reduction with PVP, compared to patients with less then 50% 
or no intravertebral BME.8·13•18 All studies used either a dichotomy between no 
or presence of BME or between < 50% or more then 50% BME, while none of 
these studies used a volumetric analysis of the amount of BME on preoperative 
MR Imaging as was performed in the current study. 
Debate exists on the use of a gadolinium enhanced T1 weighted MR I 
maging scan. 18·19 The current study shows no statistical difference in pain relief 
aftP.r PVP hP.t.wP.P.n pat.iP.nt.s with small or largfl pP.rr.P.ntagP.s of int.ravP.rt.P.hral 
INDICAT.ON 
35 
BME. In order to prevent bias in the assessment ofPVP, a strict inclusion protocol 
was used in the current study, these confounders are: first, pain generated by 
acute fractures (of which up to than 85% will resolve spontaneously within 8-12 
weeks due to natural history).20•21 Secondly, confounding due to pain from multiple 
fractures, and third exclusion of patients with intravertebral clefts, since these 
36 patients are a different entity and are merely a pseudo-arthrosis of the vertebral 
body due to necrosis.22•23 Furthermore, these vertebral cleft fractures contain 
only a small area of very high signal on MR Imaging.2'1 
Some limitations exist in the current study. First, the small size of the 
study cohort (25 patients), since only single level long-standing OVCFs were 
included and patients with vertebral cleft fractures were excluded. However, 
since repeated measurements during the first post-procedural year were 
obtained in all patients, the variability is highly reduced. Secondly, no control 
group - OVCF without intravertebral BME treated with PVP - was present. The 
latter, since presence of intravertebral BME was a prerequisite for treatment 
with PVP in our institution. Since data from literature is heterogeneous and 
includes m ultilevel and cleft fractures, no clear cut outcome scores etcetera were 
used and a control group from literature could not be used. 
In conclusion, the amount of volumetric BME in long-standing single-level 
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Abstract 
Study Design. A retrospective histologic evaluation of biopsies obtained 
during percutaneous vertebroplasty (PVP) procedures as treatment. for 
presumed osteoporotic vertebral compression fractures. 
Objective. To determine the rate of unsuspected malignancy 
in bone biopsies of patients undergoing PVP for osteoporotic vertebral 
compression fractures . 
Summary of Background Data. Most vertebral compression 
fractures, which result from minimal, or no trauma have osteoporosis 
as underlying cause. The diagnosis osteoporosis is based on clinical 
and radiologic findings. Even in patients with proven osteoporosis it is 
not always the true cause of the fractures. In literature, outcomes of 
bone-biopsies obtained during vertebroplasty have been described with 
inconsistent percentages of unexpected malignancy. 
Methods. 1'o determine the rate of unsuspected malignancy, 78 
biopsies were obtained from 78 patients (18 male; 60 female; mean age, 73 
years). The histologic diagnoses of vertebral body biopsy specimens were 
analyzed in a retrospective study. 
Results. Seventy-one biopsies (91 %) obtained from 71 patients, 
were suitable for histologic evaluation. Seven biopsies (9.0%) could not 
be interpreted as a result of suboptimal quality biopsy material. The 
population included 10 patients (13%) with a history of malignancy, in this 
group no malignancy was found in the bone biopsies. In 3 patients (3.8% 
of all biopsies) previously undiagnosed malignancies, 2 multiple myeloma 
stage Ila and 1 chondrosarcoma grade I, were found. 
Conclusion. Obtaining bone biopsies during PVPs does not lead to 
increased morbidity and can verify the pathologic process underlying the 
vertebral compression fractures. Since this study showed an unsuspected 
malignancy rate of 3.8%, we recommend routine obtainment of a vertebral 
body bone biopsy, preferably using a biopsy needle with a diameter larger 
than 14 Gauge (>2.1 mm/0.083 inch), during every PVP procedure. 
INDICAT.ON 
Introduction 
The osteoporotic vertebral compression fracture (VCF) is, with an estimated 
prevalence of vertebral deformities in the Nether! ands of 18% for men and 22% for 
women above the age of 55 years, the most common complication of osteoporosis. 1•2 
The crude incidence of vertebral fractures in European man and woman aged 50 43 
to 79 is 5.711000 and 9.9/1000 per year, respectively.3 The demographic group in 
which the osteoporotic VCF mostly occurs is, due to the advanced age, however, 
also prone for malignant skeletal disease and compression fractures due to 
malignant disease. 
Osteoporotic VCFs are a common cause of pain and disability. Twenty 
percent to 30% of these fractures are refractive to conservative treatment and 
become chronically painful. 1•4 Minimally invasive techniques such as percutaneous 
vertebroplasty (PVP) are increasingly used for the treatment of chronic pain and 
disability caused by osteoporotic VCFs.5•6 PVP has been found to provide safe and 
effective means of pain control, diminishing disability, and accelerating return 
to function. 7- 9 
The diagnosis osteoporosis is based on clinical and radiologic findings 
including DEXA examination. This, however, does not always reveal the true 
etiology of a VCF.5·1a-12 
In literature, outcomes of bone-biopsies obtained during PVPs have been 
described with inconsistent outcome in unexpected malignancy percentages.5·10·13 
A vertebral body biopsy acquired through the PVP needle during the procedure 
can identify unrecognized malignant bone tumors or metastasis, even in patients 
with normal results on laboratory studies.5 The aim of this study was to determine 
the value of obtaining a routinely performed bone biopsy during PVP. 
INDICATION 
Materials and Methods 
Patients 
Between July 2003 and 2007, 78 consecutive patients, 18 male (23%) and 60 
female (77%) with a mean age of 73 years (range, 48-93 years), with a total of 141 
44 painful VCFs, were treated with PVP in the Leiden University Medical Center. 
During the PVP procedures 78 vertebral body biopsies were obtained through 
the vertebroplasty needle. The 78 biopsies included specimen from 30 thoracal, 
30 thoracolumbar (Th12-L1) and 18lumbar vertebrae (Figure 1) . VCFs treated 
did not meet any of the radiologic criteria for possible malignancy and were since 
assumed to be the result of osteoporosis.14 The population included 68 patients 
(87%) without any history of malignancy and 10 patients (13%) with history of 
malignancy. The group of patients with known history of malignancy consisted 
out of patients with carcinoma of the lung (n = 3), prostate (n = 1), mamma (n 
= 1), larynx (n = 2), and colon (n = 1) and furthermore 1 case of gastrointestinal 
stromal tumor and 1 malignant fibrous histiocytoma. 
Inclusion criteria were (I) focal back pain in the midline refractive to at 
least 6 weeks of conservative treatment, (II) back pain related to the location of 
the VCF on magnetic resonance imaging (MR Imaging), (III) the presence of bone 
marrow edema on MRI short-[tau]-inversion-recovery sequences in the collapsed 
vertebral body, (IV) age over 40 years and (V) written informed consent. 
Exclusion criteria were (I) spinal cord compression or stenosis of the 
vertebral canal >30% of the local canal diameter, (II) neurologic deficits, (Ill) 
bleeding disorders, (IV) infections related to the vertebral column, (V) inability 
of the patient to lie in prone position for 2 hours, and (VI) an American Society 
of Anesthesiologists-score equal to, or larger than 4. The medical history of all 
patients was checked for pre-existent malignancy and possible dissemination. 
INDICAT.ON 
Imaging 
Of all paLients, AP and laLeral conventional radiographs a nd short-[tau]-in-
version-recovery MR images of the spinal column were acquired. All MR images 
were analyzed by a senior radiologist. Signs which were actively sought for 
and criteria for a suspected malignancy included: signal inhomogenicity, a 
major homogenous but nonlinear area with abnormal signal intensity, convex 
angulation of the posterior wall of the vertebral corpus without sharp a ngulations, 
multiple lesions in the vertebral column, especially at non adjacent levels, 
inhomogeneous spread in the lamina and disappearance of the basivertebral vein. 14 
Statistics 
Results are presented as means± SD (range). All analysis were performed using 
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PVP was performed under local anesthesia and conscious sedation using a 
biplane angiography unit with the patient placed in prone position. Preferably 
using a transpedicular approach, a lOG (3.4 mm) vertebroplasty needle (Optimed 
GmbH, Germany) was advanced into the pedicle and through the posterior wall 
46 of the VB using a small mallet. 
When very s mall pedicles in the thoracic region were encountered, a 12G 
(2.8 mm) vertebroplasty needle was used. Subsequently, a bone biopsy was taken 
using a 14G (2.1 mm) bone biopsy needle (Cook Medical, Limerick, Ireland), 
which was advanced through the PVP needle. The bone biopsy needle used was 
5 cm longer than the vertebroplasty needle, and facilitated the opportunity 
to advance the biopsy needle beyond the tip of the vertebroplasty needle into 
the corpus. The placement of the biopsy needle was monitored by continuous 
fluoroscopic guidance to prevent endplate or cortex damage. When the biopsy 
needle was optimally placed, a luer-lock syringe was connected to the biopsy 
needle. By pulling the plunger a vacuum was created and after rotating the 
needle 5 times, the biopsy needle was retracted. After progression of the PVP 
needle into the anteromedial third of the vertebral body, PMMA bone cement was 
injected. The specimens were kept moist using sterile saline, placed in a sterile 
container and sent to the Pathology department. The specimens were fixated 
in paraformaldehyde, decalcified in formic acid for 4 hours, and embedded in 
paraffin. The histologic specimen were stained with a hemotoxylin and eosin and 
interpreted by a pathologist. If during this analysis signs of a malignancy were 
found, additional stainings, including specific immunohistochemic testing for 
CD-138, the presence of monoclonal IgA and kappa expression were conducted. 




Seventy-one biopsies (91 %) obtained from 71 patients were suitable for histologic 
evaluation. The specimen with a diameter of 1.6 mm had a mean length of 5.9 
mm (SD, 3.00; range, 1- 15 mm). Seven biopsies (9.0%) with a mean length of 5.5 
mm (range, 0.5-8 mm), consisted of too little or scant material (N = 5, 6.4%), or 
crushed material (N = 2, 2.6%), which could not be indisputably interpreted. 
Out of 71 biopsies, 3 cases (3.8%) showed malignancy, which was not 
suspected on preoperative imaging or clinical symptoms. The 3 diagnosed 
unsuspected malignancies included 2 male patients (age 71 and 7G years) with 
cases of multiple myeloma stage Ila (Figure lA) a nd a female (age 83 years) 
with chondrosarcoma grade I (Figure lB). 
In 38 of 71 (53.5%) of the biopsies, reactive changes due to bone 
regeneration, growth, and remodeling was seen. In the group of 8 patients with 
a history of malignancy and no radiological suspicion of malignancy causing 
the fracture, and since were treated for aasumed osteoporotic VCFs, no signs of 






Figure 1. Histologic findings of unsuspected malignancy. A, Low-power photomicro· 
graph with hematoxylin and eosin staining, showing hypercellulariLy due to in terstitial 
infiltration of plasma cells. B, Magnification of Lhe plasmacel-rich areas in Figure A con· 
t.aining clustered plasma celJs with round nuclei, sporadically containing a nucleolus. 
'!'his specimen combined with a positive CD 138 staining and monoclonal expression of 
IgA a nd Kappa are consistent with the diagnosis of multiple myeloma. C, Low-power 
photomicrograph with hematoxylin and eosin staining, showing pre-existent laminar 
bone entrapped by chondroid matrix. D, Magnification of Figure C showing chondro· 
cytes with hyperchromatic nuclei surrounded by an inconsistent amoun t of eosinophil 
cytoplasm. Multinucleated cells are more than sporadically present, consistent with a 
chondJ:osarcoma grade I. 
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Discussion 
Given the prevalence of osteoporosis, in the population of patients with VCFs, 
most patients are presumed to have osteoporosis as the ultimaLe etiology causing 
their compression fractures. The diagnosis of OVCF before PVP is based on 
clinical and radiologic findings. These preoperative investigations do not always 
provide a correct diagnosis as shown in other studies.5•10•11•12 Lymphoma, multiple 
myeloma, and metastatic carcinomas are also prevalent in the same age-group 
as osteoporosis and pathologic compression fractures often can not be reliably 
diagnosed based on radiographic (including MRI) interpretation alone. 
In the current study, 3 patients (3.8%) were diagnosed with a previously 
unknown malignancy, which was diagnosed by biopsy, obtained during a PVP for 
an assumed osteoporotic VCF. The nature of the underlying pathology related 
to vertebral collapse is important regarding prognosis, assessing response to 
therapy, and long-term patient care.5 
Outcomes of bone-biopsies obtained du1ing PVPs have been described 
with inconsistent outcome in unexpected malignancy percentages varying 
from 0.7% to 7.3%, the 3.8% unsuspected malignancy rate in patients treated 
with PVP reported in the current study is higher than percentages reported 
by several other authors.5·10•13 Shindle et al. 10 found 1.3% (3/238) previously 
unsuspected malignancy (lymphoma) in their population whereas Togawa et 
aP found a 0.7% incidence (11142) of unsuspected cases of multiple myeloma 
in their population. Recently, Schoenfeld et al.13 reported a considerably higher 
percentage of unsuspected malignancies in their population. In this study, a 
7.3% (3/41) incidence of previously unsuspected malignancy including metastatic 
adenocarcinoma, lymphoma and multiple myeloma in patients treated for 
osteoporotic VCFs, was reported (Table 1). 
Schoenfeld et al. 13 and Shindle et al. 10 recommended that vertebral body 
biopsies should be performed before every vertebral augmentation procedure. 
In contrast, Togawa et aP recommended that a vertebral body biopsy should 
only be performed during each first-time vertebral augmentation procedure. The 
difference in percentages of unsuspected malignancy between Schoenfeld et al.'3 
and the current study might be explained by the size of the cohorts or differences 




Table 1. Unsuspected Malignancy in VCFs Assumed to 
Have an Osteoporotic Etiology 
Study 
Current study 
Schoenfeld et af3 
Shindle et af0 
Togawa et af 
Unsuspected Malignancy 
(Malignancies/Total No. Patients) 
3.8% (3/78 patients) 
7.3% (3/41 patients) 
1.3% (3/238 patients) 
0.7% (1/142 patient) 
Table 1. Unsuspected malignancy in VCFs assumed t.o have an osteoporotic 
etiology 
We found a relatively high number of biopsies (9%) not suitable for histologic 
examination. In other studies, this finding is, however, not mentioned. The 
diagnostic accuracy of percutaneous vertebral body biopsy has been reported to 
be 89% in the normal population and this has been found to increase to higher 
than 90% in patients with radiologic abnormalities, diagnosis or clinical suspicion 
of a malignancy, or if the biopsy involved a lytic lesion. 15-17 Because of the fact 
that the PVP needle facilitates easy access to the vertebral body, a biopsy can be 
acquired without increased morbidity and can verify the underlying pathologic 
process. In this study, a 14G biopsy needle was used to grant continuous usage of 
the same biopsy needle, independent of the usage of a 10 or 12G vertebroplasty 
needle. In clinical studies concerning vertebral bone biopsies during PVP, 
the diameter of the biopsy needle is on ly rarely mentioned. Although the use 
of a biopsy needle with a bigger diameter does not per se increase the chance 
of a correct histologic diagnosis, it is also found that the diagnosis rate was 
significantly poorer and the probability of crush artifacts increased with a 
needle diameter of less than 2 mm.18-20 In our study, crush artifacts were 
limited due to an aspiration procedure conducted by using a syringe to create 
a vacuum, this technique is also successfully conducted in other studies!8 The 
authors, however, feel that the use of a biopsy needle with the maximal possible 
diameter for the vertebroplasty needle can be advocated since the size of access 
route (the inner diameter of the vertebroplasty needle) is not altered while more 
material for histologic evaluation will be obtained. To the author's knowledge, no 
INDICAT.ON 
complications of conducting a biopsy during PVP have been published. However, 
complications due to procedures conducted solitary for the purpose of obtaining 
vertebral biopsy material, including neurologic injury, pneumothorax, fracture, 
puncture of thecal sac and bleeding, have been published. 16•21 
Undoubtedly most VCFs have an underlying osteoporotic etiology, 
nonetheless a variety of malignant conditions such as multiple myeloma and 
metastatic disease are also present in this elderly patient group.5 Phekoo et al. 
reported that the crude incidence rates of multiple myeloma increases with age 
from <5 per 100,000 at 45 to 54 years of age, to >30 per 100,000 in the group aged 
over 75 years. 22 In 70% of patients with multiple myeloma or metastatic disease 
the spine will be involved during the course of their disease.23 Moreover, both 
osteoporosis and malignancy can present in the same patient. 13 
The preoperative work-up in this patient group should include a thorough 
his tory and physical examination not only aimed on the spinal pain complaints , 
but also on possible signs of malignancy, in case of any doubt extra laboratory or 
radiologic/nuclear testing should be conducted. 
In literature, recommendations concerning obtainment of biopsy material 
during PVP procedures have been inconsistent in timing and frequency. We feel 
that the possible advantages of early detection of malignant disease outweighs 
the risks when the biopsy is taken through the PVP needle. Therefore we advise 
that not only during the first-time a patient is treated with PVP, material for 
his tologic evaluation is obtained, but also in case of new VCFs for which PVP is 
indicated. 
To obtain the best clinical outcome and to limit both morbidity and 
mortality in patients with spinal tumors, which present themselves by a VCF, 
it is important to carefully match the treatment modality to the pathologic 
process.23 We 1·ecommend routine obtainment of a vertebral body bone biopsy, 
preferably using a biopsy needle with a diameter over 2.1 mm (0.083 inch/14 
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Abstract 
In a prospective study between August 2002 and August 2005, we studied 
the quantitative Clinical and rad iological outcome 36 months after 
percutaneous vertebroplasty for intractable type-IT osteoporotic vertebral 
58 compression fractures, which had been unresponsive to conservative 
treatment for at least eight weeks. We also examined the quality of 
life (QoL). The clinical follow-up involved the use of a pain intensity 
numerical rating scale (PI-NRS, 0 to 10), the Short-Form 36 (SF-36) QoL 
questionnaire and an anamnestic questionnaire before a nd at seven days 
(PI-NRS only), and one, three, 12 and 36 months post-operatively. 
A total of 30 consecutive patients received percutaneous 
vertebroplasty for 62 vertebral compression fractures with a mean time 
between fracture and treatment of 7.7 months (2.2 to 39). An immediate, 
significant and lasting reduction in the average and worst back pain was 
found, represented by a decrease of 3.1 and 2.7 points after seven days and 
3.1 and 2.8 points after 36 months, respectively (p < 0.00). Comparison 
of the pre- and postvertebroplasty scores on the various SF-36 domains 
showed an ultimate significant increase in six of eight domains and 
both summary scores. Asymptomatic leakage of cement was found in 47 
of 58 (81 %) of treated vertebrae. Two minor complications occurred, an 
asymptomatic pulmonary cement embolism and a cement spur along the 
needle track. 
Percutaneous vertebroplasty in the treatment of chronic vertebral 
compression fractures results in an immediate, significant and lasting 
reduction in back pain, and overall improvement in physical and mental 
health. 
CLINICAL OL TCOM E 
Introduction 
Vertebral compression fractures are the most common complication of 
osteoporosis1·2 and often go unnoticed. However, one-third of patients present 
with extreme pain and limited activities of daily life, resulting in a decrease 
in the quality of life.3•4 The initial treatment of a painful osteoporotic vertebral 
compression fracture is non-operative, using a combination of analgesia, bed 
rest and bracing. Fractures resistant to such treatment are an indication for 
percutaneous vertebroplasty in which the fractured vertebra is stabilised by an 
injection of acrylic bone cement into the vertebral body. 
Percutaneous vertebroplasty is shown to result in significant and lasting 
relief from pain in 80% to 100% of patients with only a few related complications. s.s 
Notwithstanding these results, the long-term effect of percutaneous vertebroplas ty 
on the quality of life has yet to be determined. The optimal balance between the 
timing of percutaneous vertebroplasty in relation to the age of the fractuxe and 
the risk to the patient has not been fully established and varies widely.9.12 
As described by Lyritis et al. 13 two types of osteoporotic vertebral 
compression fracture can be distinguished, the more common being acute (type I) 
and characterised by a single attack of intense back pain of short duration. Type 
II is chronic and consists of sequential attacks of pain over a longer period (45 to 
60 weeks). Since natural healing of a type-I fracture occurs within four to eight 
weeks, percutaneous vertebroplasty within this time may not provide maximum 
benefit and may possibly introduce unnecessary risk. 
Our aim was to evaluate the short-(::; 12 months) and long-term (36 months) 
outcome, in terms of the quality of life, function, pain and radiological outcomes 
after percutaneous vertebroplasty using low-viscosity polymethylmethacrylate 
(PMMA) bone cement in type-II vertebral compression frac tuxes. 
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Patients and Methods 
Between August 2002 and August 2005, 30 consecutive patients with type-II 
vertebral compression fracture were prospectively recruited aL Leiden University 
Medical Centre. Four men and 26 women with a mean age of 70.7 years ( 41.5 to 
60 90.6) had a total of 139 pre-existing vertebral compression frac tures, with a mean 
of 4.6 per patient (1 to 13). Of these 139 fractures, 62 were painful and showed 
bone-marrow oedema on MR Imaging. They were treated by percutaneous 
vertebroplasty over 32 sessions. Approximately 50% of the procedures were in 
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Figure 1. Diagram showing the distribution of treated vertebra. The most commonly 
treated was Thl2, followed by the first three lumbar levels . 
The inclusion criteria were an osteoporotic vertebral compression fracture 
including that with a severe compression deformity, 14 local mid-line back pain 
refractory to conservative treatment for at least six weeks, back pain related to 
the site of the fracture on MR Imaging, the presence of bone marrow oedema in 
the collapsed vertebral body on MR Imaging T2-weighted short tau inversion 
recovery (STIR) sequences, age over 40 years and written informed consent. 
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Exclusion criteria were vertebral compression fractures due to causes other than 
osteoporosis, compression of the spinal cord or stenosis of the vertebral canal 
by > 30% of the local diameter, neurological deficits, an uncorrectable bleeding 
disorder, infection of the vertebral column, inability to lie prone for two hours, 
an American Society of Anesthesiologists score~ 415 and inability to complete a 
questionnaire. 61 
When a patient presented with pain after conservative treatment for 
six weeks, the complete clinical procedure was carried out in two weeks. This 
protocol ensured that patients were not treated by percutaneous vertebroplasty 
within eight weeks after the onset after the fracture. 
The mean length offollow-up was for 29.2 months (1 to 48). The 36-month 
follow-up was completed by 80% of the patients. Four died from causes unrelated 
to the treatment, two were unable to complete the follow-up because of severe 
cognitive problems, and one was unwilling to participate further. One patient 
had a history of leukaemia and three had metastasised carcinoma. However, all 
biopsies during the vertebroplasty confirmed osteoporosis and showed no signs 
of malignancy. The mean age of the fracture as established by the time between 
the onset of new back pain related to a radiologically confirmed fracture and the 
time of vertebroplasty was 7.7 months (2.2 to 3.9). Pre-operative anteroposterior 
and lateral radiographs and MR scans including fat-suppression sequences of the 
total spine were taken. Single-level percutaneous vertebroplasty was performed 
in ten patients (33.3%), two levels in 13 (43.4%), three levels in three (10.0%), 
four levels in three (10%) and five levels (in two sessions) in one patient (3.3%). 
The approach was unipedicular in 32 vertebral bodies (52%) and bipedicular in 
30 (48%). 
Percutaneous vertebroplasty was performed using a biplane angiography 
unit, under sedation and with the patient prone. A lOG vertebroplasty needle 
(Optimed GmbH, Ehingen, Germany) was advanced into the pedicle and through 
the posterior wall of the vertebral body using a small mallet. A bone biopsy was 
taken through the percutaneous vertebroplasty needle using a 13G Cook bone 
biopsy needle (Cook Medical, Limerick, Ireland) and, after progression into the 
anteromedial third of the vertebral body, low-viscosity PMMA bone cement 
(Osteopal-V; Heraeus Medical GmbH, Hanau, Germany) was injected using an 
Optimed Cemento gun (OptiMed Medizinische Instrumente GmbH, Ettlingen, 
Germany). If distribution of the cement in the vertebral body was unsatisfactory, 
a second needle was inserted through the contralateral pedicle, followed by 
injection of cement. 
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The aim of the procedure was to symmetrically 6Jl the central and a nterior 
parts of the vertebral body. An immediate post-operative CT scan was taken to 
reconfirm the correct positioning of the cement and to detect any leakage. 
For each patient, the pre- and post-operative clinical characteristics 
were obtai ned, including the SF-36 health survey, a 0 to 10 Pain Intensity 
62 Numerical Rating Scale (PINRS) 16 for average and worst back pain and a 0 to 
10 Satisfaction Numerical Rating Scale (S-NRS)Y·18 Health state was estimated 
by the SF-6D, 19 a preference-based measure of health derived fro m the SF-36. 
A back-pain-specific anamnestic vertebroplasty questionnaire (Figure 2) was 
used to record the clinical outcome. This contained specific questions about 
the inAuence of back pain on the activities of daily hfe. Questionnaires were 
co mpleted before and at seven days (Pl-NRS, S-NRS) and one, three, 12 a nd 36 
months after the procedure. 
Statistical analysis. 
Raw SF-36 scores were summarised and converted to a lOO-point scale, a high 
score representing a high level of function or well-being. Normality of the data 
was checked using the Kolmogorov-Smirnov test . The signi6cance of cha nges in 
the PI-NRS, S-NRS, SF-36 and the anamnestic questionnaire was assessed by 
the paired 
Student's t-test or , when the assumption of normality was not justi6ed, 
the Wilcoxon signed-rank test using SPSS version 14.0 software (SPSS Inc., 
Chicago, Illinois). A p-value of less than 0.05 was considered to be signi6cant. 
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Anamnestic Questionnaire- Overview 
Did you ex:perience back pain in the past 4 weeks? Yes No 
How much back pain did you ex:perience in the past 4 weeks? 
V try Ughtly UgbUy )1odtrale ) futb Very mutb 
How often did you experience back pain in the past 4 weeks? 
Onto or twloe A few limes Often V try often Almost a ·ery day 
On average, how long lasted back pain experienced in the past 4 weeks? 
A few nunui<S Up 10 one hour !)c,voral hours One or h>·o days Longer than two days 
Did you need to reduce your activities of daily life because of back pain in the past 4 
weeks? Yes No 
If so, on how many days (of28)? ............. Days 
How many days (of 28) did you experience limitation, caused by back pain, in carrying out your 
activities of daily life? 
.............. Days 
In the past 4 weeks, did you have difficulty with the following activities because of back pain? 
Bending or bowing down 
Lifting 5 kg 
Grasping above one's own head 
Putting on one's socks 
Standing or being busy for I hour 
Sitting in a chair for 30 minutes 
Standing up out of a chair 
;\o Yes, qulle a bit Yes. very muth Yos unno1 do 11 






Joy in life 
Not ata_u A bil :\t odoralt Quilt. bit V try mutb 
Figure 2. The questions and format of the verteboplasty questionnaire. 
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Results 
The mean pre-operative average and worst back pain scores were 7.9 and 8.8 
(5.0 to 10.0), respectively. Post-operatively the decrease in the mean average 
back pain score was 3.1 points at seven days and at 36 months (p < 0.005, paired 
64 sample t-test) and the decrease in the mean worst back pain score was 2. 7 points 
at seven days and 2.8 points at 36 months (p < 0.005, Wilcoxon signed ranks 
test). At that time six patients (25%) had no back pain (Table 1) . 
At seven days post-operatively and throughout the follow-up the mean 
patient satisfaction, using the S-NRS, deviated from indifference (score 5) and 
ranged from 8.0 to 8.5. 
Comparison of pre- and post-vertebroplasty scores on the various SF-
36 domains showed a final and significant increase in six of eight domains and 
in both summary scores, thereby indicating a significant overall increase in 
the quality of life. During the first month after percutaneous vertebroplasty, 
significant improvement was seen only in the domains of physical function (p = 
0.003), bodily pain (p < 0.001) and in the physical component score (p < 0.001) 
(Table 2, Figure 3). 
The health state utility, using SF-6D, showed a statistically significant 
increase from 0.50 pre-operatively to 0.59 (p = 0.03), 0.58 (p = 0.021) and 0.59 (p 
= 0.032) at three, 12 and 36 months, respectively (paired sample l-test). 
The vertebroplasty questionnaire showed significan t improvement 
(McNermar's test) in the activities of daily life after percutaneous vertebroplasty 
and the back-painrelated limitation in activities of daily life also decreased 
significantly (Wilcoxon signed ranks test) (Table 3A). Moreover, the intensity, 
frequency and duration of back pain decreased significantly after vertebroplasty 
(Table 3B). In those who did not experience complete relief this decrease was 
also significant, except at the long-term follow-up for the duration of episodes of 
back pain. 
In performing specified movements, only difficulty standing from a 
chair had immediate and durable significant improvement (Wilcoxon signal 
ranks test). However, the joy of life improved three months after percutaneous 
vertebroplasty (Table 3C). 
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The mean injected volume of cement per vertebral body was 5.3 ml (0.6 to 11.7). 
The immediate post-operative CT scans were examined for extra-vertebral 
leakage of cement. Of 58 treated vertebrae examined 67 sites of leakage were 
found in 47 vertebrae (81.0%) . 
Minor complications occurred in two patients. In one, leakage of cement 
during treatment of a thoracic vertebral body caused an asymptomatic cement 
embolism in the pulmonary vasculature, detected on the post-operative CT-scan. 
In the other, a spur of cement was present which followed the track of the needle 
from the pedicle to the subcutaneous tissues. This was removed immediately, 
resulting in a post -operative haematoma and low pain, which resolved within 
two days. 
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Figure 3. Bar chart showing the SF-36 difference in physical component and mental 
component scores between screening and the respective follow-up points (M CS, mental 
component score; PCS, physical component score). 
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Table 3B. Outcome of the vertebroplasty questionnaire r elating to back pain charac-
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Table 3C. Outcome of the vertebroplasty questionnaire relating to specific activi ties 
a nd miscella neous characteristics. 
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Discussion 
The benefits of percutaneous vertebroplasty depend on the selection of the 
patient, suxgical skill, complication xates a nd procedural characteristics such 
as the viscosity of the cement, the filling volume and distrib ution. Hitherto, 
there have been no definite criteria for the selection of patients for percutaneous 
vertebroplasty.9·12 It is known that 80% of all symptomatic osteoporotic vertebral 
compression fractures are acute (type I) and heal naturally within four to eight 
weeks, whereas the remaining 20% are chronic (type II) and heal spontaneously 
after 45 to GO weeks.13•20·22 Since the introduction of percutaneous vertebroplasty, 
both types have been treated by this technique.12•23•24 
Treatment of acute vertebral compression fracture results in an 
immediate and significant decrease in pain in most cases. This is the only true 
benefit compared with conservative management24·27 and may be one of the key 
factors in the success of percutaneous vertebroplasty. However, because this 
technique is not without risk,28.33 the decision as to whether to undertake it 
before eight weeks from the onset of symptoms should be made according to 
careful riskbenefit analysis and the experience of the surgeon. 
Our mean decreases in the average and worst back pain are in accordance 
with figures reported in meta-analyses,33•34 a nd from several other prospective 
studies investigating the effect of percutaneous ver tebroplasty on pa tients with 
type-II osteoporosis. 35·38 
Although the sever ity of pain is generally used as the primary outcome 
measure, the change in quality of life reflects the overall effect of treatment. 
Despite the successful use of the SF-36 in evaluation of the quality of life in 
patients with osteoporotic vertebral compression fractures,3.4 back pain39·40 and 
spinal suxgery,41•42 there are only three prospective s tudies specifically examining 
the effect of percutaneous vertebroplasty on the quality of life using the SF-
3622·43·44 and these are characterised by poor response rates, limited follow-up 
(::=: 12 months) a nd the use of different types of bone cement. To our knowledge, 
our study is the first analysis of prospectively collected data on the quality of life 
three years after percutaneous vertebroplasty with one type of cement and with 
a response rate of 80%. 
A comparison of the pre- and post -vertebroplasty scores in the various 
SF-36 domains has shown a significant and clinically relevant45 increase in six of 
eight domains and both summary scores, thereby indicating a significant overall 
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increase in the quality oflife. Pre-operative SF-36 scores were substantially lower 
than for gender-corrected scores of the average Dutch population of 65 to 7 4 years 
and above, 46.47 and comparable with those in patients with osteoporotic vertebral 
compression fractures who are suitable for vertebral augmentation.23•43•44•48·50 
During the first month after operation significant improvement was seen 
70 only in the domains of physical function, which is known to have the highest 
correlation with physical ability, 18•51 and bodily pain, reAecting the results of t he 
numerical pain score. The role physical and role emotional domains showed an 
obvious, albeit nonsignificant decrease in the first month, probably due to general 
post-treatment role-inhibiting behaviour. There was a significant improvement 
in six of eight SF-36 domains at follow-up at three and 36 months in our series. 
This contrasts with the study of Do et al,23 in which a significant improvement 
in seven of eight domains had already occurred during the first month after 
percutaneous vertebroplasty. The general health domain perceptions showed 
no improvement throughout the follow-up period, which is in accordance with 
other similar studies.23•43 Our role emotional domain results agree with others48•49 
and show no long-term significant improvement. The physical component score 
showed an immediate, significant and lasting increase, whereas the mental 
component score had a gradual, but eventually significant increase after more 
than 12 months (Figure 3). The only two studies which have reported SF-
36 summary scores showed a significant increase in both summary scores as 
early as one month after percutaneous vertebroplasty.23•44 The delayed response 
in improvement in scores may be because our study included only patients 
with type-II osteoporotic vertebral compression fractures, whereas other 
studies enrolled patients with acute and possibly type-I osteoporotic vertebral 
compression fractures. 24•44 Because of the longer period patients had more severe 
pain and disability and therefore recovery might have been prolonged. However, 
despite working against the natural decrease in quality of life with ageing,46·47 
the amount of improvement was comparable.22•43•44 
Health state utility, using the SF-6D, showed a statistically significant 
increase from 0.50 pre-operatively to 0.59 at three and 36 months after 
percutaneous vertebroplasty, indicating a post-operative health state, which 
was 18% higher. 
The vertebroplasty questionnaire used in our study has not yet been 
formally validated, but resembles the questionnaire of Evans, Kip and Boutin.52 
When our prospective study began, neither their questionnaire nor any other 
validated vertebroplasty specific questionnaire was avai lable. The back-pain-
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related limitation in activities of daily life also decreased significa ntly after 
percutaneous vertebroplasty. Moreover, the intensity, frequency a nd duration of 
back pain decreased significantly. These outcomes are in line with those of the 
SF-36 and indicate that the improvement in the SF-36 scores is due to a decrease 
in the problems which are prevalent in patients with an osteoporotic vertebral 
compression fracture. 71 
The rate of asymptomatic leakage of cement was comparable with that of 
other studies,6.38•53 as was our minor complication rate (6.7%).24•38 
The limitations of our study were the small sample size, the lack of 
specific recording of the use of analgesics during follow-up and the absence of a 
control group. Another limitation was that the SF-36 is a generic healthrelated 
instrument, which might be influenced by ageing a nd eo-morbidity. 
We have shown an immediate, significant and lasting improvement in 
pain and overall physical and mental health after percutaneous vertebroplasty. 
However, the decision as to whether to perform percutaneous vertebroplasty 
should be made carefully and according to risks a nd potential benefits for each 
patient. 
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Abstract 
Study Design. Compar·ative, prospective follow-up study. 
Objective. Comparison of outcome between patients treated 
with Percutaneous VertebroPlasty (PVP) using low and medium viscosity 
80 PolyMethylMetAcrylate (PMMA) bone cement. 
Summar y of Background Data. Viscosity is the characterizing 
parameter of PMMA bone cement, currently the standard augmentation 
material in PVP, and influences interdigitation, cement distribution inside 
the vertebral body, injected volume and extravasation, thereby affecting 
the cl inical outcome of PVP. Currently, low, medium, and h igh viscosity 
PMMA bone cements are used interchangeably. However, effect of viscosity 
on clinical outcome in patients with Osteoporotic Vertebral Compression 
Fractures (OVCFs) has not yet been explicit subject of investigation. 
Methods. Follow-up was conducted using a 0 to 10 Pai n Intensity 
Numerical Rating Scale (PJ-NRS) and the Short Form 36 (SF-36) Quality 
of Life questionnaire before PVP and at 7 days (Pl-NRS only), 1, 3, and 
12 months after PVP. Injected cement volume, degree of in terd igitation, 
and cement leakage were analyzed on direct postoperative computed 
tomography scanning. At 6 and 52 weeks and at suspicion, patients were 
ana lyzP.cl for nP.w f ractu rP.s. 
Results. A total of 30 consecutive patients received PVP using 
low viscosity PMMA bone cement (OsteoPal-V) for 62 OVCFs, followed 
by 34 patients who received PVP using medium viscosity PMMA bone 
cement (Disc-0 -Tech) for 67 OVCFs. Results regarding PI-NRS and SF-
36 were comparable between both groups. Postoperative comparison of 
injected cement vol ume, degree of interdigitation, proportion ofb i pedicular 
procedures, incidence of new vertebral fractures a nd compl ications 
revealed no differences between both groups. Viscosity was identified as 
a risk factor for the occurrence of cement leakage (yes/no, OR: 2.925, 95% 
confidence interval: [1.072-7.9811, P = 0.036). 
Conclus ion. No major differences in clinical outcome after PVP in 
OVCFs using low and medium viscosity PMMA bone cement were found . 
Viscosity ofPMMA bone cement was identified as an independent predictor 
of cement leakage. 
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Introduction 
Over the past 2 decades, percutaneous vertebroplasty (PVP) has gained popularity 
as a treatment modality for osteoporotic vertebral compression fi·actures (OVCFs). 
Promising results from large case series1 and nonrandomized controlled trails 
have been reported,2·4 and its position has been stated by professional societies.5 81 
Randomized controlled trails to establ ish the efficacy of PVP are currently being 
conducted. 6·8 
However, the mechanism of pain relief with PVP is as intriguing as it 
is unknown. Possible mechanisms may include thermal or chemical effects on 
nerve endings and more likely a mechan ical effect of sLabilizaLion of (micro) 
movement within t he fracture.9•10 
For this purpose, multiple types of injectable bone cements like 
PolyMethylMetAcrylate (PMMA), calcium phosphate, and composite cements 
are currently being used in PVP. PolymeLhylmeLacrylaLe is the most widely used 
cement type due to its good handl ing properties, strength, long Lime experience, 
and low costs. 
Viscosity, the most indicative parameter of the flowing capability of a 
liquid, is one of the main characterizing parameters of PMMA bone cement, 
and because of its effect on the interdigitation (penetration in cancellous bone), 
on~ of t.h~ fl'lct.ors pl'lrf.ir.ull'lrly l ik~ ly f.o i nflu~nr.~ t.his sf.l'lhilizl'lf.ion ~ff~r.t. l'lnrl t.h~ 
resulting mechanical properties of the treated vertebra, 11•12 and hence, outcome 
ofPVP. 
Additionally, viscosity affects the spatial distribution of cement in the 
vertebral body (VB), 12 which, when inadequate, could alter the pattern of load 
transfer and might thereby induce new (adjacent) VCFs. 10•13•14 
Concomitantly, viscosity of bone cement is also an essential parameter 
regarding extra vertebral bone cement leakage, 11·13 one of the most common 
side effects of PVP and detected in up to 87.5% of treated vertebra 15.17 with, 
although generally asymptomatic, occasionally severe results as paraplegia, 18 
neurologic deGciLs,19•20 pulmonary and cardiac cement embolisms,21 ·23 and cardiac 
perforaLion.24•25 
CEMENT LEAKAGE & CLASSIFICATION 
However, the degree to which these various manifestations of bone cement 
viscosity affect the clinical outcome of PVP is still unclear. In this study, we 
aimed to evaluate the clinical outcome ofPVP in patients with OVCFs refractive 
to at least 8 weeks of conservative treatment in terms of patient clinical outcome, 
i.e., pain and quality of life (QoL), as well as cement leakage, interdigitation, and 
82 complications in patients treated with either low or medium viscosity PMMA 
bone cement. 
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Materials and Methods 
Between August 2002 and August 2007, 64 patients were prospectively recruited 
for participation in a follow-up study on the clinical significance of viscosity of 
injected bone cement in PVP in chronic OVCFs at the Leiden University Medical 
Centre. 
T nclusion criteria were (T) Osteoporotic VCF, includi ngseverecompression 
fractures,26 (TI) focal back pain in the midline refractive to at least 6 weeks of 
appropriate conservative treatment, (Ill) back pain related to the location of the 
VCF on Magnetic resonance imaging (MRI), (IV) the presence of bone marrow 
edema (BM E) on MRI 'J'2-weighted short tau inversion recovery sequences in the 
collapsed VB, (V) age over 40 years, and (VI) written informed consent. 
Exclusion criteria were (1) VCFs due to other causes than osteoporosis, 
(ll) spinal cord compression or stenosis of the vertebral canal >30% of the local 
canal diameter, (Ill) neurologic deficits, (IV) incorrectable bleeding disorders, (V) 
infections related to the vertebral colum n, (VI) inabili ty to lie in prone position 
for 2 hours, (VI) an American Society of i\nesthesiologists score 27 >=1, and (VII) 
inability of the patient to complete questionnaires. 
ln the period August 2002 to August 2005, 4 men (13%) and 26 women (87%) 
wit.h a mP.an age of 70.7 years (rangP., 11.n-80.fi) rP.r.P.ivP.ci PVP using low-visr.osit.y 
PMMA bone cement (OsteoPal-V, lleraeus Medical, Germany) for 62 OVCFs in 
32 sessions. At t he time of the PVP procedure, 30 patients had a total of 139 
preexisting VCFs, with a mean of 4.6 VCFs per patient (range, 1 -1 3). Of these 
139 VCFs, 62 were painful, showed BME on MRl and were treated with PVP. 
Following August 2005 until August 2007, 34 patients, 10 men (29%) and 
:l4 (71%) women with a mean age of 71.0 years (range, 1H.5-!:W.H) received PYI-', 
using medium-viscosity PMMA bone cement (Disc-0-Tech, Disc-0-Tech Medical 
Technologies Ltd., Israel) for 67 OVCFs in 34 sessions. A total of 139 pre-existing 
VCFs were noted (4.1 per patient; range, 1-10), whereas 67 VCFs were painful 
and showed BME on MRI and were treated with PVP. Group characteristics 
were comparable (Table 1). 
When a patient presented with persistent pain after 6 weeks of 
conservative treatment, t he complete clinical workup was conducted in 2 weeks 
ensuring that patients did not receive PVP within 8 weeks after commencement 
of the VCF. 
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Tn Lhe work-up for PVP, anLeroposLerior and laLeral radiographs and MRT, 
including faL suppression sequences, of Lhe LoLal spine were acquired. FracLure 
morphology was denominated according to the classification from Genant et 
al,28 and was comparable between both groups, as was fracture age (Table 1). 
Fracture age was defined as the time between the onset of new back pain related 
Loa radiologic conllrmed fracLure and Lhe Lime of PVP. 
Cement leakage, defined as the presence of any extravertebral cement, 
was assessed independent of the treating physician by 2 investigators (S.P .J .M. 
and M.J.N.) using a computed Lomography (CT) scan made direcLly afLer 
PVP. Differences were re-examined unLil consensus was obtained. Patterns of 
cemenL leakage are described using the classification proposed by Yeom eL al,29 
identifying 3 types of leakage sites: (1) via the basivertebral vein (B-Lype), (2) via 
the segmental vein (8-type), and (3) through a cortical defect (C-type, Figure 1). 
Intra- and extracorporal volumes were measured using OsiriX, an open source 
calibraLed DigiLal Tmaging and Communications in Medicine (DTCOM)-viewer. 
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Figure 1. Computed tomography-scan of a vertebra after PVP. Two leakage pat-
terns are clearly visible: 1 S-type leakage site (arrow) a nd ] B-type leakage site (ar-
rowhead). 
l n addition, the degree of interdigitation of bone cement was scored on a 
semiquant,it,ative scale ranging from 1 (complete interdigitation throughout the 
injected volume with clearly visible bone trabecles) to 1 (no interdigitation at 
all with sharp boundaries along the cement clump, comparable to cleft filling) 
by 2 investigators (S.P.J.M. and M.J.N.) (Figure 2). In case of nonuniformity in 
scores, cases were re-examined until consensus was obtained. 
The PVP procedure in detail has been described previouslyY In s hort, 
PVP was performed on a biplane angiography unit using conscious sedation. 
After advancement of a 10-G vertebroplasty needle (Optimed Gmbll, Germany) 
into the VB, a bone biopsy was obtained and PMMA bone cement was injected 
using an Opt,imed Cemento gun (Opt,imed GmbH, Germany) until satisfactory 
distribution of the cement, i.e., symmetrical fi lling of the central and anterior 
parts of the VB, was achieved. When necessary, a second needle was advanced 
into the VB through the contralateral pedicle, followed by injection of cement. 
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Figure 2. Interdigitation score. A, Grade I , complete interdigitation between bone 
trabecles; B, Grade 2, cons ide1·able interdigitation a long the boundat·ies of a clearly 
recognizable cement deposit; C, Grade 3, a clump like filli ng pattern with spa1·sely gross 
interdigitation; D, Grade 4, a sharply demarcated cement clum p wi th no interdigitation 
at all. 
The PMMA bone cement is a 2-componcnt liquid methyl methacrylate and 
polymer powder mixture which, after mixture, cures from a liquid to a solid 
phase. During the curing phase, viscosity increases with time and temperature. 
Bone cement was prepared as stated by the respective manufacturers in order 
to obtain the specified cement properties. The PVP procedure was tai lored at 
optimal filli ng of the VB and patient safety and was not altered due to the type 
of cement used. Qualification of cement viscosity is cited here as stated by the 
manufacturer. 
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Pre- and postoperative cl inical characteristics of each patient were obtained 
using the Short Form (SF)-36 health survey30·32 and a 0 Lo 10 Pain Intensity 
Numerical Rating Scale (Pl-NRS) for mean and worst back pain. 33 Questionnaires 
were filled out before the procedure and at 7 days (Pl-NH,S only), 1 month, 3 
months, and 12 months after the procedure. Routine standing anteroposterior 
and lateral radiographs of the spine were made 6 weeks and 1 year after PVP 
and on indication, e.g., sudden new onset of back pain suspect for a new OVCF. 
Statistical Analysis 
Raw SF-3G iLem scores were summarized and transformed Lo a 100-poinLs 
scale, with a higher score representing a higher level of function or well-being. 
Longitudinal analysis of PI-NRS and SF-36 was performed using mixed model 
analysis based on maximum likelihood estimation. Distribution and skewness 
of data were assessed, as was normality using the Kolmogorov-Smirnov Lest. 
Where appropriate, the (paired) Student t test, the Mann-Whitney U test, 
the lchil2 test, Fisher exact test, and the log-rank test were used. A multiple 
logistic regression analysis was carried out to identify predictive factors for the 
occurrence of cement leakage. Using multiple linear regression analysis, factors 
independenLly associated with the volume of cement, leakage were assessed. 
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Results 
Preprocedurally obtained PI-NRS and SF-36 scores were comparable between 
both groups (Figure 3, Table 2). Mean average and worst back pain scores 
were respectively 7.9 and 8.8 for the group treated with low viscosity cement 
88 (LVC-group) and 7.5 and 8.5 for the group treated with medium viscosity cement 
(MVC-group), and showed 7 days after PYP a significant decrease of 3.1 and 2.7 
(LVC-group, P = 0.112 and P = 0.337). 
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Figure 3. Average (A) and worst (B) back pain. Both were found to be significantly 
and consistently lower after PVP (P = 0.142 and P = 0.337 respectively). 
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Table 2. Sf·36 Screening Scores and Differences Between Scores at the Respective Follow-Up Points and the 
Screening Scores 
Ch:at~ge Screetung- 1 Chatge Scletrung-3 Cllange Sereening- 12 
Screening Month Month Month 
Mean so N Mean so N Mean so Mean so 
PCS 
lVC 2S.S3 s.31 30 1.46 8.59 23 7.19 8.46 22 7.93 12.00 18 < 0.001 
MVC 26.02 8.23 34 2.46 8.01 27 6.12 9.36 2S S.ll l14 28 "c 0.713 Ove1 all elect 
Of visCOSlty: 
" - 0.569 
MCS 
lVC l9.51l 11.74 30 -4J$ 11.50 23 131 1.93 22 3.49 9A1 18 llOIII 
MVC 40.1~ 1101 34 3.68 9~2 27 1.18 10.14 2S s.os 14.46 28 
P • O.lll Ovet all elect 
ot viscosity: 
I' • 0.211 
Nottltc1 of bOnt ctment ~4Y'"*'Idtn~tfled fOt PCS !P • 0 SS9t Fot MC$. notftc-1 of bmt Ot VI$CO$fl.V w.H fovndtP • 0 058~ P • 0 2'71. rtsQttttvtlyt 
PCS •ndc.,tts phv$1(.81 eomconent score. MCS. mentot eompanent Jeort; LVC. ~ YISOMII.V ettnent. MVC. med~utn VlSQOSti'V etmet~t SO. s.~ c5tvlab01\ 
Table 2 . SF-36 !>creening !>core!> a nd difference!> between !>core!> at Lh e re!>pecLive 
follow-up points and the screening scores. 
Comparison of 1 month postvertebroplasty scores on the 8 domains and both 
component (summary) measures of the SF-36 showed a significantly higher 
increase on the domain "Physical Functioning'' and the "Physical Component 
Score" for theLVC group compared to theMVC-group, whilescoringon the domain 
"Role Physical" and the "Mental Component Score" was significantly higher for 
the MVC-group compared to the LVC-group). At 3- and 12-months follow-up, 
SF-36 scores on all domains and both summary measures were comparable. The 
Physical Component Score was significantly increased at both follow-up points, 
whereas the Mental Component Score was not (Table 2, Figure 4). 
Of 62 vertebrae in the LVC group, PVP was unipedicular in 36 (58.1 %) 
cases and bipedicular in 26 (41.9%), whereas the procedure was unipedicular in 
45 (62.8%) and bipedicular in 22 (32.8%) of 66 vertebrae in the MVC-group (P = 
0.285). 
In order to correct for eventual geometrica l, anatomic, or weight-bearing 
induced differences, injected cement volume, and interdigitation score were 
analyzed separately for the thoracic and lumbar spine. Neither the injected 
cement volume nor the interdigitation score per region differed significanLly 
between the LVC- and the MVC-group (Table 3). 
The proportion of vertebrae with detected cement extravasation was 
signiGcanLly higher in the LVC-group (87.9% vs. 71.6%, P = 0.029, Table 4) . A 
subsequent multiple logistic analyses identified cement viscosity to be associated 
with the occurrence of leakage (yes/no), P = 0.036, Table 5). The distribution of 
leakage types was similar in both groups (Table 4). 
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90 SF-36 at Screening 
PF 
VT 
--+-- LVC Screening 
· ·•· MVC Screening 
SF-36 at 3 months follow-up 
PF 
VT 
-+-LVC 3 months 
---MVC 3 months 
SF-36 at 1 month follow-up 
PF 
VT 
-+-- LVC 1 month 
--•- MVC 1 month 
SF-36 at 12 months follow-up 
PF 
VT 
-+-- LVC 12 months 
--• - MVC 12 months 
Figure 4. SF-36 Domain scores at various follow-up points. Baseline domain scores 
were comparable between both groups. At 1 month PF was significantly higher in the 
LVC-group (P = 0.03), whereas RP was significantly higher in the MVC-group (.P = 
0.01). At 3 and 12 months, all domain scores were similar in both groups. PF indicates 
physical functioning; .RP, role physical; BP, bodily pain; GH, general health percep-
tions; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health. 
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Table 3. Comparison of Vertebrae Treated, Average 
Cement Volume, and Interdigitation Score per Region 
Between Both Groups 
level lVC MVC Region 













p = 0.148 
lnjecte<l Cement Interdigitation 
Volume (mU Score U-IVI 
lVC M'IC (lVC/MVCI 
Thoracic 4.66(n a 311 4.27(n = 431 1: 11/10 111:6/12 
11: 11/19 IV: 1/2 
p = Q372 p = 0.481 
lumbar 6.02(n = 291 4.91 (n = 241 1:11/12 Ill: 9/8 
11:8/4 IV: 110 
P• 0.081 p . 0.576 
LVC tndicatts low VISCOSity cement; M\'C. m&dium VISCOSity cement. Th. 
lhofac•c: L ll.W'nbat. 
Table 3. Comparison of vertebrae treated, average cement volume, and interdigita-
tion score per region between both groups. 
A multiple linear regression revealed fracture severity, the number of 
extravasation sites, and the injected volumes to be independently associated 
with leakage volume (Table 5). In the LVC-group, 14 new fractures, of which 
9 adjacent to treated levels, occurred in 10 patients (33.3%) after a mean of 
6.8 months (1.3-13.6), whereas in the MVC-Group 17 new fractures, of which 
10 adjacent, occurred in 9 patients (26.5%) after a mean of 1.2 months (0.03-
11.9). One VCF occurred 1 day after PVP. In 2 patients in the LVC-group and 4 
patients in the MVC-group, these fractures were treated using PVP. Proportion 
of patients with new OVCFs, proportion of adjacent fractures, time distribution, 
and mean time to occurrence of new fracture were comparable between both 
groups (P = 0.380, P = 0.756, P = 0.080, and P = 0.071, respectively). 
Two minor complications, 1 asymptomatic pulmonary cement embolism 
and 1 cement spur following the needle tract from the pedicle to the subcutaneous 
tissue, which was removed immediately, occurred in the LVC-group. In the MVC-
group, in 2 patients a similar cement spur was noted after surgery. Proving 
asymptomatic, the spurs were not removed. 
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Table 4. Leakage Specifications 
Cement 
Group 1: LVC Group 2: MVC 
OsteoPai-V Disc-0-Tech p 
Vertebrae with leakage 51 of 58 (87.9%) 48 of 67 (71.6%) 0.029 
Type according to Yeom et a/ 
B 21 (28.8%) 19 (22.4%) 
s 18 (24.7%) 26 (30.6%) 0.567 
c 34 (46.6%) 40 (46.8%) 
Into discus 32, (43.8%) 38, (44.7%) 0.762 
LVC indicates low viscosity cement; MVC, medium viscosity cement; B. via 
the basivertebral vein; S, via the segmental vein; C. through a cortical defect. 
Table 4. Leakage Specifications. 
Table 5. Results of Regression Analysis 
Multiple logistic regression for presence 
of cement leakage (yes/no) 
Severity according to Genant et at 




Multiple linear regression for log tota l 
volume of cement leakage 
Severity ace. to Genant et a/ 




No. leakage sites 
Cl indicates confidence interval. 
Table 5. Results of regression analys is. 
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Besides injection technique and bone- and fracture-related parameters, cement 
properties influence cement flow, distribution, and volume inside the VB, and 
thereby ultimately the outcome of PVP. 
Viscosity of bone cement used m PVP is hypothesized to influence 
the outcome of the procedure in various ways. One way is by determining or 
affecLing the potential of the cement to interdigitate with the trabecular bone, 
and thereby its potential to stabilize (micro)movements in the fractured vertebra 
and relief pain, as well as preserve its mechanical strength. 11•12•34 In addition, 
it is unclear whether spatial distribution of the cement, also influenced by 
cement viscosity, 12·35 affects the ouLcome of PVP and the risk of subsequent 
(adjacent) vertebral fractures by alteration of the distribution of load and its 
transfer over the VB.10•13· ~-~·36•37 llence, placement of a second needle through the 
contralateral pedicle, and thereby introducing substantial additional risks and 
costs, is frequently opted for· when the distribution of cement is unsatisfacLory or 
asymmetrical. Hemivertebral filling through a un ipedicular approach appears 
as effective as using a biped icular approach though.38·40 
Regarding the procedure itself, more viscous cement has better handling 
properties, especially in controlling the amount and speed of injection. Downside 
of Lh~ high~r viscosity is Lh~ high~r injP.r.f.ion pr~ssur~s r~quirP.ci12•41 anrl Lh~ 
volume of injectable cement can therefore be limited, necessitating conversion 
from a uni- to a bipedicular approach. 
Above all, however, viscosity of cement is a crucial parameter regarding 
the main cause of (severe) complications of PVP, being extravastion of cement 
outside the VB. 11· 13•41 Despite its proven superiority over radiography for 
detection of cement leakage,16•29 CT-scanning after PVP is infrequently executed 
for this purpose, rendering most reported cement leakage incidences invaluable. 
Reported in up to 87.5% of treated vertebrae on postoperative CT-scanning15·17 
and generally asymptomatic, extravasation of cement inside the spinal fora men 
or the venous circulation can result in neurologic deficits, paraplegia, pulmonary 
and cardiac embolisms, or cardiac perforation.18·25 
I n PVP, low, medium, and high viscosity PMMi\ bone cements are used 
interchangeably. Effects of viscosity, (optimal) injected volume and distribution of 
cement in relation to cement leakage and restoration ofbiomechanical properties 
of fractured vertebra have been investigated in experimental or cadaver studies 
or using finiL~ ~l~m~nL analysis.9·12•36·38•40•41 How~v~r, pal.i~nl. dinir.al signifir.anr.~ 
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has not yet been explicit subject of investigation and an in vivo direct comparison 
of clinical outcome between groups treated with PVP using identical injections 
methods, but bone cements with different viscosities has, to the authors' best 
knowledge, not been reported thus far. This study focused on the effect of bone 
cement viscosity on the clinical outcome of PVP using periprocedurally and 
94 prospectively acquired (follow-up) data from 2 patient groups which have been 
treated with PVP for OVCFs using low and medium viscosity PMMA bone 
cement. 
For the LVC- and the MVC-group, our results showed a clinically 
relevant,33 significant, immediate, and durable reduction in average back pain, 
respectively 3.1 and 2.6 at 7 days and 3.3 and 3.2 at 1 year, and worst back 
pain respectively 2. 7 and 2.8 at 7 days and 3.1 and 3.0 at 1 year, which was 
comparable between both groups. Increase in QoL, measured using the SF-36, 
was similar in both groups. 
Comparison of mean injected cement volume per vertebra per region 
revealed no significant difference, although a tendency was seen toward injecting 
less cement in the MVC-group. The degree of interdigitation of bone cement was 
also found to be similar in both groups, thereby contrasting the expectation of 
more pronounced interdigitation or uniform filling facilitated by higher viscosity 
cement.11•12 This is supported by the similar proportion ofbipedicular procedures 
in both groups, being an indication of the simi lar spatial distribution of cement 
inside the VB and the comparable number of and mean time to development of 
new OVCFs after PVP in both groups. 
In the MVC-group, a sign ificanLiy smal ler proportion of treated vertebrae 
exhibited cement leakage (71.6% vs. 87.9%, P = 0.029). In order to correct for 
eventual confounders, a multiple logistic analysis was carried out and revealed 
cement viscosity to be significantly associated with the occun:ence of cement 
leakage (yes/no, P = 0.036), the risk of occurrence of cement extravasation using 
LVC being nearly 3-fold compared to when using MVC (OR, 2.925; 95% confidence 
interval, [1.072-7.984]). Despite its intuitive nature, this is actually the first 
study proving this hypothesis in vivo and confirming experimental results. 11•12 
The amount of cement extravasation was found to be independenLiy 
associated with the volume of injected cement, the number of leakage sites, 
and the semiquantitatively graded severity of the fracture. No independent 
association with viscosity was found. Trivially, when intraoperative cement 
leakage is noted, further injection of cement should be done with great care and 
the number of leakage sites as well as the fracture severity should be kept in 
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mind, predisposing for a greater amount of cement leakage with potentially more 
severe sequelae. Whether or not the severe leakage described with low-viscosity 
ccment,20 due to its predisposition for taking the "path of least resistance," 
resulting from intravertcbra1 irregularities, 11•12 will be reduced using high 
viscosity bone cement remains unconllrmed. 
A limitation of our study was the subsequent treatment using low and 
MVCs in study cohorts instead of randomized usage of both cements, thereby 
unable to cancel out effects of an operator learning curve and increased 
expectations of patients as a result of the gradual general awareness of the 
procedure and its results. Other limitations arc the lack of measurement of 
injected cement viscosity and degree of osteoporosis. 
In conclusion, in experienced hands, viscosity of PMMA bone cement used in 
PVP for OVCFs did not influence clinical outcome. The immediate and durable 
reduction in pain and improvement in QoL was comparable between both groups, 
as was the injected cement volume, degree of interdigitation, proportion of 
bipedicular procedures, incidence of new vertebral fractures and complications. 
Cement viscosity, however, was identified as an independent predictive factor 
for the occurrence of cement leakage. In the presence of cement extravasation, 
leakage volume is associated with injected cement volume, number of leakage 
sites and fracture severity. 
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Abstract 
Purpose. The majority of clinically relevant complications after 
Percutaneous VertebroPlasty (PVP) are due to cement leakage. A 
radiological classification of these cement leakages should be reproducible 
100 precise and logical. The currently used classification systems, provide no 
information on the anatomical location and volume of the cement leakage, 
making it impossible to determine which leakages lead to clinically 
relevant complications. 
Aim. The aim of this study is to test a new system for Evaluation 
of eXtra vertebral cement leakage in vertebroplasty based on Anatomy and 
volume of the leakage using CT-scan analysis (the EXACT classification 
system) with superior discrimination potential. This system describes 
spatial distribution and anatomical structures of the leakage in addition 
to the Cement Leakage Volume. 
Materials and methods. The direct postoperative CT-data of 
106 vertebral bodies from 53 patients, treated with PVP were analyzed. 
Leakages were analyzed according to the system published by Yeom et al., 
and using the new anatomy based classification system. 
Results. The inter-observer variability, using the new scoring 
RyRtP.m waR 0.94 (p<O.OOl), which is comparah!P. to t.hP. intP.r-ohsP.rvP.r 
variability of 0.97 (P<O.OOl) found when using the system of Yeom et al. 
In addition to the leakage volume, the new system identified leakage sites 
more specific in terms of anatomical and spatial distribution compared to 
the classification system according to Y eo m et al 
Conclusions. The new system facilitates research, investigating 
divergence in leakage patterns of different cement types available on 
the market and to register specific cement leakages and possible clinical 
sequelae. 
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Introduction 
Since Percutaneous VertebroPlasty (PVP) was introduced in 1989 as a 
minimal invasive procedure for the treatment of painful Osteoporotic Vertebral 
Compression Fractures (OVCFs), the procedure gained popularity because of its 
high effectiveness in fast pain reduction. 1 Fast, significant and clinically relevant 
relief of symptoms and restoration of mobility, is achieved in more than 80% 
of patients in multiple large studies.2·4 Moreover, PVP has many advantages 
compared to extensive surgery due to its minimal invasiveness, and relatively 
low costs. 
Due to two recent randomized blinded controlled trials, which showed 
no beneficial effect of vertebroplasty compared to a sham procedure, specialists 
became more alert on possible negative side effects of the procedure.5•6 The new 
insights called for more accurate registration of possible negative side effects 
and complications of the PVP procedure. 
The rate of complications with a clinical sequel of PVP is low and is 
reported to range from 1.6% to 2.8%.7 The reported complications with PVP in 
OVCFs however range from apparently clinically silent unanticipated advents 
to catastrophic clinical outcome and death.8·11 The vast majority of the clinically 
relevant complications of PVP are due to leakage of bone-cement. Severe 
complicM.ions :uP. r:-JrP. :-1nrl m:-1inly occur in C:-JRP. of high volumE'! cP.mP.nl'. lP-1-lk:-JgP.. 
Reported complications include cement entering the nerve root foramen 
or spinal canal, resulting in radiculopathy or spinal cord compression, embolic 
events due to marrow fat or cement entering the circulation, malplacement of the 
needle, rib fractures, pneumothorax, fracture of processus spinosus or pedicle, 
subcutaneous paravertebral hematoma and infection. 12·18 
In PVP, PolyMethylMethAcrylate (PMMA) bone cement is the most widely used 
type of cement. There's a wide variety of PMMA cements types with different 
viscosity available. The viscosity is often categorized as low-viscosity (comparable 
to yoghurt), medium viscosity (comparable to toothpaste) and high viscosity 
(comparable to dough). These types of cement are clinically used interchangeably, 
despite of the fact that literature suggests that there are differences in frequency 
volume and leakage types between the cement types used.19•2° Currently, still 
new types of PMMA cement are introduced to the market without certainty 
concerning its potential leakage behavior. 
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So far, accurate and comparable data concerning the risk of clinically relevant 
complications due to specific cement leakage types are unavailable. This is 
partly due to a lack of radiological (i.e. CT) follow-up and the lack of a clinically 
applicable classification system for cement leakages. 
The only paper specifically describing and testing a leakage 
102 classification system is by Yeom et al in 2003.18 This classification system, divides 
cement leakages in Basivertebral (B), Segmental (S) and Cortical (C) but gives 
no information on the anatomical location and volume of the cement leakage and 
may therefore lack clinical relevance. 
Papers concerning cement leakage describe a variety systems, which 
are based on the system published by Yeom et al. and show resemblances but 
are however not similar enough to compare the outcomes in a detailed meta-
analysis.21.26 In order to faci litate more accurate registration of cement leakages, a logical, 
accurate, and reproducible cement leakage classification system is mandatory. 
The aim of the current study was therefore to develop and test a new 
system for Evaluation of eXtra vertebral cement leakage in vertebroplasty based 
on Anatomy and volume of the leakages using CT-scan analysis (EXACT system). 
This system describes spatial distribution (anterior (A.x.x), medial (B.x.x) or 
posterior (C.x.x)) and anatomical structures (venous system (x.l.x), cortical 
defect (x.2.x)) of the leakage and specific sites (e.g. vein or discus) in addition 
to the cement leakage volume (x.x.0.5cc)(Figure 1). For venous leakages (xlx), 
5 types are recognized by their anatomical location (anterior external plexus, 
the basivertebral vein, the segmental vein, the anterior internal plexus a nd the 
posterior internal plexus (Figure 2), a comprehensive description of the vertebral 
venous structures has previously been published by Groen et aJ.27 
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Figure 1. Overview of the EXACT anatomy based scoring system. 





Figure 2. Shows a schematic drawing of the anatomy of the vertebral venous system. 
A; Anterior External Plexus (AEP), B: Basivertebral Vein (BV), C: Anterior Internal Ve-
nous Plexus (AlP), D: Segmental Vein (SV), E: Posterior Internal Venous Plexus (PIP). 
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Patients and Methods 
Data were collected from 53 patients treated for 106 painful OVCFs between 
January 2008 and January 2009. All patients underwent a post-intervention 
CT-scan using a standardized protocol and a sLandard multi-slice CT-scanner 
(Thoshiba Aquilion 64 slice, slice thickness: l.Omm, Gantry-tilt: 0 degrees, X-ray 
tube kilovoltage (KVP) 135, X-ray tube currenL 250, Exposure time 500) 
The 106 vertebral bodies (VB) from 53 patients were divided into three 
regions. 1) Thoracic region, in which T5-T10 were grouped, (37 VB (34.9%)), 2) 
Thoraco-lumbar region, in which T11-L2 were grouped, (50 VB (47.2%)), and 3) 
Lumbar region in which 13-15 were grouped (19 VB (17.9%)). 
Calibration 
The direct postoperative CT-data of the 106 vertebral bodies (VB) treated with 
PVP were analyzed using a calibrated DICOM viewer (Osirix 3.3, 64 bit, Kagi, 
Berkeley, California) . The Osirix DICOM viewer was calibrated by CT-analysis 
of cement volumes injected in 8 cadaveric pig vertebrae, which were hermetically 
sealed in a container of gelatin and scanned on the same CT-scanner, which was 
used during the clinical experiment. The analyzed ver tebral bone was dissolved 
in hydrochloric acid and the volume of the remaining PMMA-cement was 
determined by water-displacement volume try. Mter measurement of the actual, 
in vitro, cement-volume, 3D growing region segmentation was calibrated using 
a fixed lower pixel threshold of 100, and a fixed upper threshold of 10.000. This 
wide window could be used due to the high difference in opacity of the opacified 
bone-cement compared to the surrounding vertebral bone. All specimens were 
tested and all volumes were calculated 4 times. Mter calibration, the CT -analysis 
was found to be accurate up to 0.01mL ofPMMA cement. 
Analysis of CT -data 
Analysis of the CT-data acquired from the treated patients in our cohort 
included: 1) vertebral level; 2) Cement Leakage Volume, defined as the total 
cement volume outside of the cortical border of a treated vertebral body and is 
acquired by adding the volume of all solitair cement leakages in a single treated 
vertebral body; 3) Total Cement Volume , defined as the total volume of cement 
within the vertebral body (including the volume trabecular bone captured 
within the injected cement) and outside the cortical boundaries of the vertebral 
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body; 4) cement leakage classification according to Yeom et al.; and 5) cement 
leakage classification ace. to the new classification system. All vertebral levels 
were graded by 3 independent observers experienced in assessing skeletal CT-
scans, using both the classification system according to Yeom et al. and the new 
classification system. 
Statistical Analysis 
A probability value of <0.05 (two-tailed) was considered statistically significant. 
The intra-class correlation coefficient for leakage category scoring was tested 
for absolute agreement using a two-way mixed model where people effects are 
random and measures effects are fixed in SPSS statistical software 16.0, 
(SPSS Inc, Chicago, IL). 
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Results 
Classification according to the EXACT system showed a total of 124 leakages. 
In the thoracic region, 46 leakages were detected (1.24 leakage sites!VB). Mean 
cement leakage volume in the thoracic region was 0.33 mL and ranged from 0.02 
to 1.76 mL. In the thoraco-lumbar, region 6lleakages were detected (1.24leakage 
sites!VB). Mean cement leakage volume in the thoraco-lumbar region was 0,47 
mL (range 0.02-5.59 mL). In the lumbar region 17 leakages were detected (0.89 
leakage sites!VB). Mean cement leakage volume the lumbar region was 0,32 
(range 0.02-3,61 mL). Of all leakages, 53 (43%) consisted out of a cement volume 
2: 0.25 mL a nd 28 (23%) out of 2: 0.5 mL. Of these larger leakages, 38 (72%) were 
located t,hrough the superior and inferior endplates B2.1 and B2.2, and 9 (17%) 
into the anterior internal plexus C1.1 (rablel, Figure 3). Mean total cement 
volume was: 3.82 ±1.45 rnL in the thoracic region, 5.26 ±2.04 mL in the thoraco-
lumbar region and 6.57±2.15 mL in the lumbar region. 
Classification of the leakages according to the classification system of 
Yeom et al. also showed 124 leakage sites of which 30 type B (Basivertebral 
vein leakage), 29 typeS (segmental vein leakage) and 65 type C (Cortical defect) . 
Table 2 demonstrates the subdivision of cortical and venous leakages in relation 
to the system of Y eo m et al. 
The inter-observer variability (int.ra -r.lass observer r.orrelat.ion) of ~ 
independent observers for the EXACT classification system, was 0.94, the inter-
observer variability when using the classification system according to Yeom et 
al. was 0.97 (P<0.001). 
Yt."'mt'tal. Currt'nl study 
8 s c Al.l A2.1 A 2.2 81.1 811 1!2.1 82.2 CLI Cl.2 C2.1 C2.2 C2.3 
T 11 9 26 6 I I I 4 13 10 9 I 0 0 0 
Tl. 15 14 32 7 3 I 0 6 15 13 14 0 0 0 0 
L 4 6 7 2 I 0 0 3 I 4 4 I 0 0 2 
30 29 65 16 5 2 I 13 29 27 29 0 0 0 2 
(24%) (23%) (52%) (13%) (4%) (2%) (I%) (10%) (24%) (22%) (22%) (2%) (0%) (0%) (2%) 
Table 1. Cement leakage per region according to Yeom et al. and the EXACT classifi-
cation system. (T=thoracic region,TL= thoracolumbar region, L= lumbar region). 








• E 4,00 , 
0 3,90 > 
• 3,80 0> • " • 3,70 .! 
















1,10 " " X ' 1,00 X " 





" ~ 0,50 ~ XI> " 
0 
0,40 " "0 " I XThor.lcic (TS.T10) " • 0,30 " I X 0 
I 
1> Thofaco.l.umbar (T1H2) 
I 
x ~ I 
' 
0,20 0 X OLUII'bar (LJ.LS) 
h:& ~ 
0 
0,10 ~ 0,00 X 
A1.1 A2.1 t-2.2 81.1 812 82.1 82.2 82.3 C1.1 Cl.2 C2.1 C22 C2.3 
Figure 3. Cement leakage volume (mL) per anatomical class according to the EXACT 
system. 
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al.l Anterior external venous plexus 1------~~~~~~~L,,.,.,.,.,.,.,.,.,..,.,.,.,.,J 
a2.1 Singe anterior leak (cortical) 








b 1.1 Basivertebral vein 
b 1. 2 Segmental vein 
b2 .1 Superior end plate/discus 
b2. 2 Inferior endplate/discus 
).. b2 .3 Lateralleak (cortical) 
E c1.1 Anterior internal venous plexus ~~~~~~~E~~~~~1:::::3 2 
~ c 1. 2 Posterior internal venous plexus 
ClJ c2.1 Posterior wall corpus (cortical) 
c2. 2 Medial pedicle wall 
C2 .3 Needle traject 
Total 30 Total 29 
Basivertebral (B) Segmental (S) 
Total65 
Cortical (C) 
System according. To Yeom et al. 
~ Overlap new system and ace. to Yeom et al. 
Table 2. Comparison overview of the number and distribution of leakages in the EX-
ACT classification system versus the classification system according to Yeom et al. 
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Discussion 
In 2009, two randomized, blinded, controlled trials, have been published.M 
Both trials showed no beneficial effect of vertebroplasty compared to a sham 
procedure among patients with painful osteoporotic ver tebral fractures. An even 
110 more rece nt randomized study however showed that vertebroplasty is superior 
compared to conservative treatment. The outcome of the former two trials, 
which showed no beneficial effect of vertebroplasty, made specialists more alert 
on possible negative side effects of the procedure.28•29 Because both papers were 
simultaneously published in the prestigious New England J ournal of Medicine, 
the results had a major effect on physicians, media a nd public. The new insights 
called for accurate registration of possible negative side effects and complications 
of the PVP procedure. 
In ligh t of the renewed emphasis on critical judging of complications and 
possible side-effects of the PVP procedure, research should be conducted using 
understandable, reproducible and precise outcome measures. 
As cement leakage is reported to accoun t for the majority of complications 
of PVP, and is found in up to 88% of the PVP procedures, the leakages and their 
sequeale should be registered.30•31 Cement leakage is dependent on the injected 
cement volume and is best detected using post-operative CT-scanning.32 The 
use of CT scanning versus plain X-ray results in a increase of more than 50% 
leakage detection.30 Fluoroscopic or plain radiography imaging, which are often 
used for assessing cement leakage, are insufficient to collect enough information 
concerning the effects of the leakages. Both the exact anatomical position as well 
as the volume of the leakage is very difficult to assess. Schmidt et al. found in 
their s tudy that the agreement rate between fluoroscopy and CT scans ranged 
from 66% to 74%, while inter-observer reliability showed only fair agreement . 
Especially leakages in the basivertebral veins were frequently misinterpreted.30 
To objectivate the clinical outcome after PVP or other procedures, 
nu merous well-tested questionnaires have been developed over the years (Short-
Form 36 (SF36), Roland-Morris disability score, visual analogue score (V AS)) .33·35 
However, when investigating the complication rate in PVP, in which the most 
prevalent complication is cement leakage, there is no classification system to 
evaluate the clinical consequences of cement leakage. 
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In vertebroplasty the complication rate is low (1.6% - 2.8%), but mainly due 
to cement leakage.7 So far, the "common" cement leakage in PVP, is said to be 
without clinical consequences in the majority of cases. Clinical relevance of 
cement leakages is highly dependant on the site of the leakage. Leakage to the 
neuro-foramen or the spinal canal might result in neurologic complications.10 
Furthermore, leakage to the intervertebral disc could lead to altered biomechanical 
stress to the adjacent vertebral body and could possibly cause an increased risk 
of new fractures.36 Leakages to arterial or venous structures are reported to 
cause pulmonary embolism, and have been reported to be present in up to 18% of 
patients after a PVP procedure. 12 Even cardiac perforation and cerebral cement 
embolism have been reported .9· 12•37 Without a precise system to measure cement 
leakage in order to correlate these outcomes to possible clinical consequences of 
these leakages, a good insight in the dangers of cement leakages during PVP can 
not be made. 
When using the classification system published by Yeom et al., leakages of 
cement are classified into th ree types: 1) Type B- leakages via the basivertebral 
vein - these leakages involve leakage of cement into the spinal canal. They 
proceed via the vascular foramen and in the spinal canal they follow the epidural 
venous plexus, 2) Type-S - leakages via the segmental vein - these leaks often 
proceed horizontally, in line of the segmental veins. They therefore often mimic 
a small paravertebral leak on anteroposterior radiographs. They are, however, 
often long leaks, and may reach the neural foramina and finally Type-C -
through a cortical defect around a vertebral body, including the spinal canal. 
Leaks into the spinal canal for example therefore may be scored as a type-B or 
type-C leakage, when using the system according to Yeom et al. 18 No information 
concerning the anatomical position or the volume of the leakage is provided using 
the aforementioned system. Moreover, cottical leakage (C) in the system ofYeom 
et al. are grouped in one category, hereby discarding all information concerning 
structures which could be at risk at specific sites. 
When using the EXACT system, in which not only insight concerning the 
specific anatomical position of a leakage is added to the classification but also 
the leakage volume. All information about spatial distribution (anterior (A.x.x), 
medial (B.x.x) or posterior (C.x.x)) and anatomical structures (venous system 
(x.l.x), cortical defect (x.2.x)) of the leakage a nd specific sites (e.g. vein or discus) 
and the cement leakage volume (x.x.0.5 mL) are combined into one classification. 
Due to the anatomical description of the leakage combined with a spatial 
classification, a more accurate registration ofleakages is possible (Figure 4). 




Figure 4. Shows the practical implementation of the new classification system. A: 
axial image of the treated corpus shows no venous leakage and no leakage through the 
anterior, la teral or posterior cortex. B and C: sagittal images show a leakage through 
the superior endplate into the discus (3.6 mL). D : coronal reconstruction shows the 
leakage centrally through the superior end plate. When using the system of Yeom et al. 
and thus neglecting were the leak penetrates through the cortical bone, the fact that it 
concerns a high-volume discus leakage, this leakage would be a type C. According to the 
EXACT classification this leakage would be a B-2-1-3.6 mL. 
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The current study showed that, when using the EXACT system, the majority of 
larger leakages (2>:0.5 mL) occur through the endplates into the intervertebral 
disc, which will lead to altered forces applied to the adjacent levels and possibly 
even to new vertebral fractures.38•39 Furthermore in 17% of the leakages ;::0.5 mL, 
the anterior internal plexus is involved, a structure which is situated within the 
spinal canal. 
As with every classification system, inter-observer variability should 
be as low as possible. When categories are too much alike, the interobserver 
variability will rise making the classification system less reliable. The proposed 
system has, due to its high precision in describing the anatomical and spatial 
distribution, more categories in which the observer could place a certain cement 
leakage than in the system published by Yeom et al. The intra-class correlations 
of the EXACT system (0.94, p<O.OOl) was comparable to the interobserver 
variability of 0.97 (P<O.OOl) found when using the classification system ace. to 
Yeom et al. 
While this study provides a logical, precise and reproducible new 
classification system for cement leakages during PVP, some limitations should 
be noted. This system is only applicable when postoperative CT scans are 
routinely performed. Some categories (Cl.l and C2.2) in the new system, were 
not encountered during this study, the authors however feel that if leakages at 
these sites do occur, a high chance of clinical consequences is to be expected. 
Considering that the PVP procedure is being scrutinized due to the 
publications in NJEM in 2009, combined with the knowledge that there is a 
lack of adequate data concerning leakage frequency and patterns, the growing 
evidence on the role of viscosity, and the fact that still new types ofPMMAcement 
are introduced to the market, calls for a reliable registration as is currently done 
in other types of prosthesis. 
When using the EXACT system, leakage sites can be more specifically 
identified as compared to the classification according to Yeom et al. The EXACT 
system has an obvious value in research of the PVP procedure and the types 
of cement used during the procedure. The authors furthermore expect t he 
EXACT classification system to be of greater clinical value. Implementation of 
the EXACT system and registration of leakages on large scale data facilitates 
pooling data from different centers and offers the possibility to gain important 
new insight into which leakages are to be expected to lead to clinically relevant 
complications and which viscosity types of cement are more likely to result in 
clinically relevant cement leakages. 
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Abstract 
Vertebral compression fractures are the most prevalent complication of 
osteoporosis and percutaneous vertebroplasty (PVP) has emerged as a 
promising addition to the methods of t,reating the debilitating pain they 
122 may cause. 
Since PVP was first reported in the literature in 1987, more 
than 600 clinical papers have been published on the subject. Most report 
excellent improvements in pain relief and quality of life. However, these 
papers have been based mostly on uncontrolled cohort studies with a 
wide variety of inclusion and exclusion criteria. In 2009, two high-profile 
randomised controlled trials were published in the New England Journal 
ol Medicine, which led care providers throughout the world to question 
the value of PVP. After more than two decades a number of important 
questions about the mechanism and the effectiveness of this procedure 
remain unanswered. 
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Osteoporotic Vertebral Compression Fractures 
Osteoporosis is the most frequent cause of vertebral compression fractures 
(VCFs) in the elderly} In 2000, over 40.000 new vertebral fractures due to 
primary or secondary osteoporosis were registered in The Netherlands.2 With an 
ageing population it is expected that this number will only increase with time. 
The generally preferred initial treatment of patients with a symptomatic stable 
osteoporotic VCF without attendant neurological symptoms is conservative.3 In 
85% of symptomatic patients, pain caused by these 'acute' osteoporotic fractures 
will settle within 12 weeks of starting conservative treatment. <~-6 The remaining 
15% with 'chronic' osteoporotic compression fractures, can fail to respond to 
conservative treatment, and there may be an indication for percutaneous 
vertebroplasty (PVP). 
The effect of PVP on pain is reported to be rapid and to reach a plateau 
within a few days of the procedure,7 after which the pain scores do not change 
significantly over the following two years.S-11 A meta-analysis of 60 studies by 
Eck et aP2 reported a change in the visual analogue scale (V AS) score. After 
PVP patients improved from a mean pre-operative VAS of 8.36 (SD 0.78) to a 
mean post-operative VAS of 2.86 (SD 1.09), with a mean statistically significant 
change in the level of pain of 5.68 (SD 1.24). After two high-profile randomised 
controlled trials, by Buchbinder et aP3 and Kallmes et al, 14 were published in the 
New England Jonmal of Medicine in 2009, care providers began to question the 
value of injecting cement into fractured vertebral bodies and revived discussion 
about the evidence for, the mechanism of and the risks involved in PVP. 
Percutaneous Vertebroplasty 
PVP is a procedure used to stabilise fractured vertebrae in order to relieve pain. It 
involves the injection of bone cement, usually polymethylmethacrylate (PMMA), 
and an opacifier into the inter-trabecular marrow space of a fractured vertebra. 
The procedure may be used for pathological compression fractures caused by 
osteoporosis, avascular necrosis, multiple myeloma or bone metastases. 15-17 In 
general, patients are selected on the basis of the following: incapacitating pain 
at the level of the fracture which is unresponsive to conservative treatment;18 
focal point tenderness, which increases when pressure is applied to the spinous 
process of the fractured vertebra;19-21 and bone marrow oedema in the fractured 
vertebral body on MR Imaging with fat suppression. 22-25 
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The first PVP was performed by Deramond in 1984 and reported in the literature 
in 1987.26 A paper in the American Journal of Neuroradiology in November 
199727 describing a trial from the University ofVirginia which comprised29 patients 
followed over a period of three-years, with promising short-term outcomes, 
prompted a sudden increase in the number of procedures being performed. 
124 PVP may be performed under general anaesthesia, although more 
commonly the patient is given a local anaesthetic at the injection site and 
conscious sedation. The procedure takes between 1 and 2 hours, depending on 
the number of vertebrae requiring treatment. Mter its injection into the vertebra, 
the cement hardens and prevents further collapse of the vertebral body, and is 
thought to support the micro fractures in the trabeculae. 
As well as 'traditional' PVP, there is a similar procedure in which it is used 
in combination with an inflatable balloon tamp often referred to as kyphoplasty. 
This was developed in the early 1990s and gives comparable clinical outcomes.12 
The evidence for performing kyphoplasty is, however, beyond the scope of this 
review and therefore will not be discussed further. 
According to a number of large studies, relief of symptoms and 
restoration of mobility are rapidly achieved in more than 80% of patients after 
PVP. Most of these studies are, however, of evidence level IIIB or IV. 15•17•25•28 
The rate of complications after PVP is reported to range between 1.6% and 
2.8%.29 The reported complications with PVP in osteoporotic VCFs, however, 
range from unanticipated and apparently clinically silent events to catas trophic 
complications and even death. 12•30-32 Most of the clinically relevant complications 
are due to leakage of bone cement. Severe complications are rare and occur 
mainly in cases of high-volume cement leakage. Complications include cement 
penetration of the nerve root foramen or spinal canal resulting in radiculopathy 
or spinal cord compression, embolic events due to marrow fat or cement entering 
the circulation, misplacement of the needle, rib fractures, pneumothorax, 
fracture of spinous process or pedicle, subcutaneous paravertebral haematoma 
and infection. 10•33-38 
Leakage of cement into the neural foramen or spinal canal can cause 
neurological injury.32 Furthermore, leakage, especially into the intervertebral 
disc, may lead to altered biomechanical stresses on the adjacent vertebral body 
and an increased risk of new fractures.39 Leakage into the arterial or venous 
system has been reported to cause pulmonary embolism, cardiac perforation and 
cerebral cement embolism.40•41 Alongside these reported complications, it appears 
that the prevalence of new fractures in PVP-treated patients is between 12% and 
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more than 50%.39•42-48 Research on the development of new compression fractures 
after PVP has been conducted in biomechanical models and clinical trials.4S-50 Up 
to 70% of new fractures after PVP are adjacent to a previously treated level. 47•51 
The main difficulty in conducting clinical trials to answer the question 'Does 
PVP increase the risk of subsequent fracture of the adjacent vertebral body?' is 
that in a patient who has already sustained one compression fracture the risk of 125 
developing a new fracture is increased, whether the previous fracture has been 
treated or not.52-;;.~ Biomechanical testing may explain why secondary adjacent 
fractures occur in patients with a wedge compression fracture, as the mechanical 
load on the endplate changes from perpendicular to a shearing off-axis load. 55 
The exact mechanism of pain relief by cement augmentation of the 
vertebral body is still debated; it has been suggested that bone cement stops 
vertebral micro- or macromovement and is consequently responsible for the 
analgesic effect of the procedure. 56 However, there appears to be no correlation, 
in terms of pain relief or t he use of medication, between the degree of cement 
filling of the fractured vertebral body and the clinical outcome. 57 Due to its rapid 
analgesic effects, high effectiveness, low complication rate and relatively low cost, 
over the past two decades PVP has become a widely used, minimally invasive 
treatment for painful vertebral compression fractures, despite the unknown 
mechanism of pain relief and the lack of studies with a high level of evidence. 
Uncontrolled Clinical Vertebroplasty Trials 
(Level IV Evidence) 
Since 1987 more than 600 clinical papers about PVP have been published. The 
largest trials to date are those conducted by McGraw et aP5 (100 patients), 
Evans et al58 (245 patients), Kobayashi et al28 (175 patients), Alvarez et al25 
(278 patients), Layton et aP0 (552 patients) and Masala et al11 (624 patients), 
which were mostly non-randomised and retrospective. They report markedly 
different patient selection criteria, duration of follow-up and outcome measures, 
but uniformly encouraging results for short-term pain relief in the vast majority 
of patients. The s tudy by Masala et al11 also showed that the significant mean 
reduction in pain achieved (6.5 points on a VAS) four hours after the procedure 
was unchanged one year later. However, without any form of concurrent or 
historical control group it is impossible to be confident of the true benefits of 
PVP. Some or all of the improvement might be caused by the favourable natural 
course of a n osteoporotic VCF,6 or by a placebo effect. 59 
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Non-Randomised Controlled Clinical Vertebroplasty Trials 
(Level Ill B Evidence) 
In 2003, Diamond, Champion and Clark60 conducted the first non-randomised 
controlled trial of PVP against conservative treatment in 79 patients. This study 
showed a significant and immediate effect on pain relief, with improved function 
126 and red uced use of analgesics after 24 hours. However, it also showed that the 
effect might be short-lived. Substantial improvements seen in the conservatively 
treated group resulted in there being no clinically important differences between 
the two treatment groups in pain or function at six weeks or between six and 
12 months.54 •60 The lack of randomisation in this study raised the possibility of 
selection bias, although both groups of patients had similar characteristics before 
treatment. Furthermore, without blinding the patient to the treatment received, 
it is impossible to disentangle the treatment effect from the placebo effect. 
Randomised Controlled Clinical Vertebroplasty Trials 
(Level liB Evidence) 
In 2002, Do et al61 randomly assigned 31 patients with acute VCFs to PVP or 
continued medical treatment. This study suggested improvements in pain, 
activity a nd a nalgesic use six weeks after intervention. 
In 2007, Voormolen et al9 compared PVP with optimal pain medication 
(OPM) in the VERTOS I study. They reviewed 34 patients who had suffered 
from painful osteoporotic VCFs for more than six weeks but no longer than six 
months, and randomised them to PVP or OPM. As nearly all of the patients 
randomised to the OPM group req uested to cross over after two weeks, the study 
was stopped early. Th is suggested that pain relief, improved mobility, function 
and stature after PVP are immediate and significantly better in the short term 
than following OPM treatment.9 To gain more insight into the cost-effectiveness 
ofPVP, a second trial (VERTOS II) was conducted by Klazen et al62•63: the results 
were published in The Lancet in 2010. In this trial, 202 patients with back pain 
lasting for six weeks or less as a result of an osteoporotic VCF were randomly 
allocated to PVP or conservative treatment. Inclusion criteria included focal 
tenderness over a compression fracture with a minimum of 15% loss of vertebral 
height, osteoporosis, and bone marrow oedema on MR Imaging. The primary 
outcome was the relief of pain after one month and one year using a VAS. This 
showed that vertebroplasty resulted in greater pain relief than conservative 
treatment. The authors concluded that pain relief after vertebroplasty is 
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immediate, is sustained for at least a year, and is significantly greater than that 
achieved with conservative treatment.62 
Randomised Controlled Blinded Vertebroplasty 
Trials (Level IB Evidence) 
A number of authors have emphasised the importance of randomised blinded 
controlled trials of PVP in order to obtain level I evidcnce.56•59•60•64•65 So far, three 
such trials have been conducted. In 2002, Kallmes at al66 conducted a small, 
single-blinded, randomised crossover study in which five patients with subacute 
vertebral fractures were included. The control procedure involved the injection 
of local anaesthetic next to the vertebral body, without introducing cement. 
Three patients initially underwent the control procedure and two underwent 
PVP. All patients in both groups had minimal relief of symptoms and chose to 
cross over to the other procedure. All patients guessed that they had received the 
control procedure first.66 However, this pilot study demonstrated the feasibility 
of enrolling patients into a sham-controlled trial of PVP.65 
In 2009, two randomised, blinded controlled trials were published. The 
INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST) conducted 
by Kallmes et aP4 randomised patients to PVP versus a control intervention in 
which local anaesthetic was injected without cement.67 Both the patients and the 
clinical coordinators who performed the follow-up remained blinded to the type of 
procedure. The primary outcomes were pain relief and Roland Morris Disability 
Scale score68 at 30 days. Patients were followed clinically for one year. 
The second randomised blinded trial by Buchbinder et al13 offers some 
potential advantages over the INVEST trial. First, in control patients a PVP 
needle was placed into the bone, but without the injection of cement, whereas in 
the INVEST trial a PVP needle was not placed in bone. This difference in design 
might have made it easier to blind patients to the type of procedure. Secondly, 
crossover was not allowed in the trial by Buchbinder, which allowed longer-term 
follow-up than was possible in the INVEST trial. 
Both the INVEST trial and the trial conducted by Buchbinder found that 
pain was significantly reduced after PVP, but that the improvement was not 
clinically more significant than that in the control groups. The overall conclusion 
of the INVEST trial was that at one month the clinical improvement in patients 
with painful osteoporotic VCFs was similar in those treated with PVP and 
those treated with a simulated procedure. The overall conclusion of the trial 
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by Buchbinder also showed no beneficial effect of PVP over a sham procedure 
after one week, or at one, three or six months, among patients with painful 
osteoporotic VCFs. 
Because both papers were published simultaneously in the New England 
Journal of Medicine, 13•14 the results had a major effect on physicians, the media 
128 and the public, and a procedure which had shown very promising results in 
numerous large cohort studies was instantly discarded by many. The high-
profile nature of the articles makes this rigorous step understandable but not 
necessarily justifiable. Even though these studies may be the only two blinded 
randomised controlled trials of reasonable size, some important considerations 
should be considered when reading these papers. 
In both studies the inclusion criteria were not the generally accepted 
indications for PVP, which are focal back pain on palpation corresponding to 
a fracture, and bone marrow oedema on MRI.8•24•25 In both studies physical 
examination was disregarded, potentially leading to the inclusion of other causes 
of back pain. Furthermore, t he study by Kallmes 1'1 lacks the standard inclusion 
criteria of bone marrow oedema, and in both studies only one-third of eligible 
patients without contraindications were included, and with these numbers a 
selection bias is highly likely. 
In the study populations of both the INVEST14 and in the study by 
Buchbinder13 a high percentage of patients suffered from acute fractures (less 
than six weeks old) . In the INVEST study 32% of the fractures were acute. In 
the Buchbinder study 44% of the fractures were of mixed age, ranging from one 
to 14 weeks old. Subgroup analysis did not demonstrate statistically significant 
differences between chronic and subchronic fractures because of the small 
numbers available. In the study populations descr ibed by Buchbinder13 and 
Kallmes,' 4 patients with pseudoarthroses after an osteoporotic VCF, which are 
known to not respond well to conservative treatment,69 were entirely missing. A 
reduction in VAS of 3 to 6 points one week after PVP is common in the literature.12 
The INVEST study showed values close to this range, with 2.3 points at day 
three to 2.9 points at day 14. Remarkably, the opposite results are shown by the 
trial by Buchbinder, a 1.5 red uction in VAS after PVP being among the smallest 
in literature a nd barely clinically relevant.70 
Fuxthermore, by presenting short-term results in both studies, t he 
natural course is not taken into account,4 which results in a lack of statistical 
power to draw any long-term conclusions. 
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Conclusions 
Indisputable level 1 evidence in favour for or against the effectiveness PVP is 
still lacking. The most probable explanation for the positive effects observed 
in prospective cohort studies still seems to be the mechanical impact of the 
bone cement. Until proven, however, this will continue to be a hypothesis. The 129 
randomised, but effectively unblinded, trials conducted by Voormolen et al9 and 
Klazen et al62 are well designed and use clear, widely used inclusion criteria, 
such as focal tenderness on physical examination and bone marrow oedema on 
MRI scan. The studies give some answers to the question 'Is PVP better than 
continuing conservative treatment for a longer period?' and suggest that pain 
relief after PVP is immediate, is sustained for at least a year, a nd is significantly 
greater than that achieved with conservative treatment. 
The randomised, double-blind controlled INVEST~<~ trial and the trial 
by Buchbinder13 were conducted with far less clear inclusion criteria, in which 
physical examination and MRI had a limited or no role in the standard work-
up. We feel that the trials by Buchbinder13 and Kallmes~<~ have made it easier to 
discuss placebo-controlled vertebroplasty trials with medical ethical committees. 
Because of these publications it is clear that a well-designed double-blinded 
randomised controlled trial using the right indications and inclusion criteria is 
fP.asihlP. and should hP. pP.rformP.d in t.hP. nP.ar futurP.. 
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The (R)evolution of Percutaneous VertebroPlasty 
Since 1984, in which Deramond performed the first PVP, vertebroplasty gained 
enormous popularity due to the encouraging outcomes of numerous follow-up 
studies. 1·5 Sometimes, vertebroplasty was considered, a "magic intervention" by 
patients (and some doctors too), that could cure all types of chronic back pain. 
Due to two widely discussed papers in the New England Journal of 
Medicine, this highly positive perspective made a 180 degree turn and promptly 
PVP was believed to be a worthless procedure by many healthcare providers.6·9 
As a result, today PVP for OVCFs is no longer part of the s tandard 
insured medical costs in the Netherlands. Although questions concerning 
the effectiveness of PVP in speci6c patient groups and the precise working 
mechanism of the procedure remain, the current research presented in this 
thesis (which was initiated before other "critics" appeared), does however not 
support this acute discarding of the PVP procedure, which is based on rather 
awkward methodology of that research. 10• 11 
Patient Selection and Indications 
Not unlike other medical interventions, the outcome of PVP is highly dependent 
on selecting the correct indications for a specific medical problem. As such, in 
general, patient selection is the keystone of a successful treatment outcome. 
In acute OVCFs, patients should be confined to a period of at least 6-
8 weeks of conservative treatment (in which up to 85% of the OVCFs will 
spontaneously heal), whilst strict inclusion criteria for PVP should be met -
including a thorough physical examination, plain radiography and MR lmaging 
-before .PV.P should be considered (see also, Chapter 7, this thesis) . 
The triad of indication criteria for painful long-standing OVCFs includes: 
I) incapacitating pain at the fractured level, with focal point tenderness, which 
increases if pressure is applied to the spinous process of the fractured vertebra, 12• 
13 II) unresponsiveness to at least 6-8 weeks of conservative treatment14 and Ill) 
intravertebral BME on MR Imaging. 
DISCUSSION & SUMMARY 
The research presented in the current thesis, showed no correlation between the 
volume of intra vertebral BME and the outcome ofPVP for long-standing OVCFs 
(see also, Chapter 2, this thesis). Other authors showed, that when treating 
patients without any signs of intravertebral BME, the outcome is significantly 
worseY· 16 Thus, these studies suggest that the mere presence of a nd not the 
volume of intravertebral BME should be used as part of the indication criteria 
strategy. Pathophysiologically this might be explained by the fact that the 
presence of intravertebal BME shows that part of the fractured vertebral body 
still is in the early phase of the fracture healing cascade, with subsequent micro-
movement in the unconsolidated vertebral body. 17 
Next to VCFs due to osteoporosis (aetiology of the majority VCFs), 
painful (pending) compression fractures due to aggressive haemangioma, 
multiple myeloma or bone metastasis and trauma are included in the indication 
spectrum for PVP. 18.20 These patients with disseminated or primary vertebral 
malignant disease have generally a poor general health condition (i.e. eo-
morbidity, chemotherapy), which makes them non-eligible for extensive spinal 
(resection) surgery. But, since PVP is performed under local anaesthesia a nd is 
performed in day-care, PVP provides a treatment modality with an acceptable 
cost effectiveness for the patient and an immediate improvement of Quality 
of Life, mainly due to pain relie£.21•22 The PVP procedure in metastatic bone 
destruction may be performed in combination with radio frequency ablation 
using CT-fluoroscopy guidance.23·26 
The value of routine bone biopsy during every PVP for a ny presumed 
osteoporotic VCF, shows an unsuspected malignancy rate of 3.8% in our 
population, with no signs of malignancy at MR lmaging. Thus we advocate a 
vertebral body bone biopsy during every PVP procedure, in order to early diagnose 
an unexpected malignancy, which can be treated, like multiple myeloma (see 
also, Chapter 3 of this thesis). 
DISCUSSION & SUMMARY 
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Clinical Outcome in Long-Standing OVCFs 
In literature, the clinical outcome of a PVP is usually presented in pain 
rating scales i.e. the visual analogue scale (VAS). Next to pain, other possible 
improvements in daily functioning can be as important as a decrease in pain, for 
example increased mobility despite presence of (less) pain, which will improve 
140 the overall Quality of Life. 
In order to make the PVP procedure more easily comparable to other 
(surgical) interven tions and to potentially calculate effect sizes, Chapter 4 of 
this thesis, evaluates the short-form 36 (SF 36) Quality of Life questionnaire in 
a prospective three year follow-up study on patients treated for long-standing 
OVCFs.27 This study showed a durable and significant improvement in both the 
domains of physical function, bodily pain and the physical componen t score and 
in both summary SF 36 scores, thus indicating a significant and durable overall 
increase in the Quality of Life after a PVP. 
Registration and Complications 
During the last decade, registration of medical implants in order to facilitate 
monitoring of implant survival and (long-term) complications, has become more 
important despite it's presence for hip prostheses since 1979.28 Registration of 
implan ts is a powerful tool to evaluate both the quality of an implant and the 
possible (long-term) complications. An important advantage, if such registration 
relates practice descriptive statistics and performance to the overall national 
level (i.e. "mirror information), is that quality at local levels will be improved.28 
In essence, the injection of non-absorbable bone cement into a vertebral body, 
which will stay in-situ for life, can also be seen as an implant . Therefore at least 
the type and volume of the injected cement and the vertebral levels should be 
registered. 
Although cement leakage as a complication is present in up to 88%, severe 
complications are rare. The latter underscoring the importance of a registry, 
which enables to identify rare complications earlier. Severe co mplications occur 
mainly in cases of high-volume cement leakage. Leakage of cement into the neural 
foramen or spinal canal can cause neurological injury.32·29.32 Next to a massive 
leakage, leakage into the intervertebral disc, may alter biomechanical stresses 
around adjacent vertebral bodies and may even pose an increased risk for new 
fractures. 33 Due to the fact that new OVCFs tend to form adjacent to an old fracture 
(even in patients who are not previously treated with PVP), large series (i.e. 
registries) are needed to proof if PVP is a potential thread to adjacent vertebrae. 
DISCUSSION & SUMMARY 
In our institution, a post-procedural CT-scan is part of the standard treatment 
protocol. On the necessity of the standard post-procedural CT-scan some debate 
exists in literature. Some authors feel that there is no need for a standard 
postoperative CT-scan due to the fact that the (acute) complication rate in PVP 
is low.33 The radiation dose of a CT-scan of the spine is also a point of concern, 
since the patient is exposed to more than 5 times the effective radiation dose 
compared to an AP and lateral plain radiograph of the spine.34•3;; If the worldwide 
registration of cement leakages is found to be important, a post-operative CT-
scan will be mandatory. 
Leakages are best detected using post-procedural CT-scan.32 The use 
of CT-scan versus a plain X-ray results in an increased detection rate of more 
than 50% of cement leakages.29 The exact anatomical position, the volume of 
the leakage as well as leakages in the basivertebral venous system can be more 
easily assessed with CT.29 In this thesis, the development of a new CT-based 
leakage classification system was described (see also, Chapter 6, this thesis). 
So far, no anatomical based classification system for cement leakage had been 
published, making it impossible to conduct uniform registration of the most 
common complication of PVP. 
The use of a low-viscosity PMMA-cement showed to triple the risk of 
cement leakage when compared to a medium viscosity PMMA cement (see also, 
Chapter 5, this thesis). Still new types of PVP cement with different viscosities 
and an unknown outcome in terms of cement leakage and possible complications 
are being introduced to the market and used in the clinical setting without any 
phased introduction to the market with good clinical control to prevent (long-
term) complications.28•36 The latter underscores the need for a cement leakage 
classification system with good validity in order to offer the best patient care 
possible: primum non nocere. 
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DISCUSSION & SUMMARY 
The battle over the treatment of patients with a painful osteoporotic vertebral 
fracture is hotting up nicely. On one side, the protagonists of vertebroplasty are 
carrying out a considerable number of these procedures and claiming significant, 
prolonged pain relief for their patients: on the other, the evidencebased medicine 
brigade can nnd no evidence that the procedure has anything other than a placebo 
effect. In their instructional review, Muijs, van Erkel and Dijkstra consider the 147 
place of percutaneous vertebroplasty in the 15% of patients who fail to respond 
to 12 weeks of conservative treatment. In its favour, they cite Eck et aP who, 
in 2008, reported a meta-analysis of the literature to date and found a mean, 
statistically significant, improvement of 5. 68 (SD+/ -1.24) in post-operative VAS 
level. More recently, however, two randomised controlled studies were published 
in the New England Journal of Medicine (the Australian2 and INVEST3 studies) 
which cast doubt on its efficacy. 
In the midst of this debate, the potential for causing harm should not be 
overlooked. Eck et al reported a 17.9% risk of new fracture, usually a tan adjacent 
level, after vertebroplasty and a 19.7% risk of cement leak. Complications may 
be catastrophic and are usually related to leakage of large volumes of cement. 
The indications for the procedure, whether effective or not, are now fairly 
clear. Patients with an osteoporotic fracture with more than 15% loss of anterior 
vertebral height, severe pain which is unresponsive to all reasonable modalities 
of conservative treatment, tenderness over spinous process of the fractured 
vertebra and bone marrow oedema on MRI imaging with fat suppression may be 
considered for treatment. It is the timing of this treatmen t that raises a number 
of issues. In the literature to date patients have been treated as early as one week 
after their fracture and as late as 12 months. Of the major randomised studies, 
The Vertos 11 study5 only included patients with back pain for six weeks or less, 
the Austrahan2 and lNVEST3 studies included patients with back pain for up to 
a year. The Vertos 11 study showed that vertebroplasty gave greater pain relief 
than conservative treatment and concluded that the pain relief is immediate, 
sustained for at least a year, and is significantly greater than that achieved with 
conservative treatment. The Australian and INVEST studies concluded that 
vertebroplasty conferred no additional benefit over placebo or sham treatment. 








These studies are not really comparable as they clearly study different 
populations. Given that the pain of an osteoporotic vertebral fractuxe will 
probably settle within 12 weeks in 85% of patients, it seems paradoxical to study 
a group in which the pain has been present for less than six weeks. Similarly, 
is it reasonable to study groups of patients who have been in pain for anything 
148 between a few weeks and a year? 
One further piece of evidence should be considered. Since the article 
by Muijs et al was accepted for publication, the authors of the Australian and 
INVEST studies have combined their findings in a meta-analysis to try to identify 
any subgroups which would benefit from vertebroplasty6. They have concentrated 
on patients with fractures of recent onset (<6 weeks) and patients in severe pain 
and have still failed to show any benefit from vertebroplasty over placebo. 
Muijs et al are certainly correct in concluding that indisputable evidence 
in favour or against the effectiveness of percutaneous vertebroplasty is still 
lacking and that further studies are needed. When these are planned, not only 
should the inclusion and exclusion criteria be crystal clear but the investigators 
should undoubtedly narrow down the population studied by duration of symptoms: 
perhaps 3 to 6 months would be sensible in the first instance. Otherwise, how 
are we to know if we should advise vertebroplasty, and if so, who to treat and 
when? 
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Summary, Conclusions & Future Perspectives 
Summary 
152 The General Introduction in Chapter 1 of this thesis provided an overview of 
the history of PVP, the PVP procedure, the indications, the outcome and the 
complications. 
In Chapter 2, the influence of the pre-procedural volume of intra vertebral Bone 
Marrow Edema (BME) on post-procedural pain relief in patients treated with 
single level PVP for long-standing OVCFs was studied. Intravertebral BME 
persists in subacute and chronic painful OVCFs due to the altered healing cascade 
of the VCF caused by osteoporosis. In most clinics, intra vertebral BME is one of 
the criteria for performing a PVP procedure. Until now, intravertebral BME has 
been assessed only by semi-quantitative grading and not by volumetric analysis. 
In this study, 25 patients (4 male, 21 female, mean age of72.0 (SD 7. 7) years) with 
a single level OVCF, with mean time between onset of symptoms and PVP of 5.7 
months (SD 2.6), were included for a prospective study. All patients underwent a 
preoperative radiograph (AP and lateral of the spine) and MR-sequence with fat 
suppression, T2 Short Tau Inversion-Recovery (STIR), of the complete spine to 
visualize intravertebral BME with sagittal reconstructions using a 5 millimeter 
slice thickness. Volumetric assessment of the intra vertebral BME was conducted 
by 2 independent observers using a visual threshold. During a 1- year follow-up, 
a Pain Intensity Numerical Rating Scale (PI-NRS) was recorded in all patients. 
In multivariate repeated measures analysis, no association was found between 
the volume percentage of BME (in the range of 10%- 70%) and post-procedural 
back pain (0.04 per 10% vertebral body volume, 95%CI: -0.18-0.26, p = 0.711). 
In conclusion, no relation between the amount of BME on preoperative MR 
imaging, quantified using volumetric analysis, and post-procedural pain relief 
in the first year after PVP was found in patients with single-level long-standing 
OVCFs. 
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Chapter 3, describes a study on the rate of unsuspected maligna ncy in bone 
biopsies of patients undergoing PVP for OVCFs. Undoubtedly, most VCFs have an 
underlying osteoporotic aetiology, nonetheless a variety of malignant conditions 
such as multipele myeloma or metastatic disease are also present in this elderly 
patient group. A vertebral body biopsy acquired through the PVP needle during 
the procedure can identify unrecognized primary malignant bone tumors or 153 
metastasis even in patients withou t any signs for malignancy on pre-procedural 
MR Imaging. Furthermore, the nature of the underlying pathology causing the 
vertebral collapse is important regarding prognosis, therapy and long-term 
outcome for those patients. In this study, the histology of vertebral body biopsy 
specimens was studied in a cohortof78 patients (mean age 73 years). In 3 patients 
(3.8% of all biopsies), previously undiagnosed malignancies - 2 multiple myeloma 
stage Ila and 1 chondrosarcoma grade 1,- were found. A routine vertebral body 
bone biopsy during every PVP procedure is recommended. 
In Chapter 4, the outcome ofPVP in patients with in tractable OVCFs, which had 
been unresponsive to conservative treatment for at least eight weeks (i.e. long-
standing OVCF), was prospectively studied by analyzing the quantitative clinical 
and radiological outcome up to three years post-procedurally. Additionally, the 
Quality of Life (QoL) was studied by using a Pain Intensity Numerical Rating 
Scale (PI-NRS, 0 to 10), the Short-Form 36 (SF-36) QoL questionnaire a nd a 
PVP-specific questionnaire. An immediate and lasting reduction in average back 
pain, bu t also in the worst back pain, was found at seven days and at 36 months 
follow-up. Furthermore, this study showed a clinically relevant increase in six 
of eight SF-36 domains and both summary SF-36 scores, indicating a significant 
overall increase in QoL. In summary, results from this study demonstrated 
an immediate, significant and lasting reduction in back pain and overall 
improvement in both physical and mental health after PVP in the treatment of 
long standing OVCFs. 
Chapter 5, describes the influence of cement viscosity on the occuxrence of 
cement leakage. Cement viscosity was shown to be significantly associated with 
the occurrence of cement leakage. The risk of occurrence of cement leakage using 
low viscosity cement was found to be nearly 3-fold compared to using medium 
viscosity cement. 
DISCUSSION & SUMMARY 
The clinical outcome after PVP or other procedures can reliably be objectivised by 
using one of the numerous well-tested questionnaires that have been developed 
over the years, as was also shown in Chapter 4 by using the PI-NRS and SF-
36 questionnaires. However, when evaluating the complication rate in PVP 
(most prevalent is cement leakage), there is no classification system available 
154 to evaluate the clinical consequences of cement leakage. So far, cement leakages 
are described according to the classification system by Yeom et al. (2003), 
dividing cement leakages in Basivertebral (B), Segmental (S) and Cortical (C) . 
This system however does not provide information on the anatomical location 
and volume of the cement leakage and may therefore lack clinical relevance. 
Chapter 6, describes the development of a new system for Evaluation of eXtra 
vertebral cement leakage in vertebroplasty based on Anatomy and volume of 
the leakage using CT-scan analysis (the EXACT classification system). This new 
classification system combines information about spatial distribution (anterior 
(A.x.x.), medial (B.x.x) or posterior (C.x.x.)), anatomical structuxes (venous 
system (x.l.x.), cortical defects (x.2.x.) of the leakage and specific sites (e.g. 
vein or discus) in addition to the cement leakage volume (x.x.0.5cc). Due to the 
anatomical description of the leakage combined with a spatial classification, a 
more accurate registration of leakages is possible. In this study, the direct post-
procedural CT-data of 106 vertebral bodies from 53 patients treated with PVP 
was analyzed according to the classification system of Yeom et al. and according 
to the new EXACT classification system by three independent observers. The 
inter-observer variability was comparable between the Yeom et al. classification 
system (0.97, p<O.OOl) and the EXACT classification system (0.94, p<O.OOl). This 
study demonstrated that the EXACT classification system provides a logical, 
precise and reproducible classification system for cement leakages in PVP and 
has an obvious value in t·esearch of the PVP procedure and the different types of 
cement used in PVP and is therefore expected to be of high clinical value. 
DISCUSSION & SUMMARY 
Finally, Chapter 7, provided a review of the scientific evidence for performing 
PVP. Since PVP was first reported in literature in 1987, more than 600 clinical 
papers have been published on the subject. Most reports demonstrate excellent 
improvements in pain relief and Quality of Life, mostly based on uncontrolled 
control studies with a wide variety of inclusion and exclusion criteria. In 2009, 
two randomised controlled trials were published in The New England Journal 155 
of Medicine, which led care providers all over the world to question the value of 
PVP over conservative treatment. In the presented review, the most important 
clinical papers are discussed in perspective to their level of evidence. After more 
than two decades, multiple important questions about the mechanism and 
effectiveness of this procedure still remain unanswered. 
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Conclusions 
• The percentage of the vertebral body filled with BME on pre-procedural 
MR Imaging, does not predict the magnitude of pain reduction when 
performing PVP in long-standing single level OVCFs. 
• While undoubtedly, most VCFs have an underlying osteoporotic aetiology, 
a routine vertebral body bone biopsy during every PVP procedure is 
recommended, since previously undiagnosed malignancies can be found 
in up to 4% of these bone biopsies. 
The Quali ty of Life analysis of PVP in the treatment of long-standing 
VCFs results in an immediate, significant and lasting reduction of back 
pain and overall improvement in both the perceived physical and mental 
health of the patient. 
• The occurence of cement leakage is significantly associated with 
PMMA cement viscosity. 
• The newly proposed EXACT classification system provides a logical, 
precise and reproducible classification system for cement leakages in 
PVP and therefore has an obvious value in research of the PVP procedure 
and the different types of cement used in PVP and is expected to be of 
great clinical value. 
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Future Perspectives 
Indisputable evidence in favour for or against the effectiveness of PVP is s till 
lacking. Prospective cohort studies support the hypothesis that the positive effect 
of PVP derives from the mechanical impact of the bone cement. Several recent 
randomised (controlled) trials have given some answers to the question 'Is PVP 157 
better than continuing conservative treatment for a longer period?' and suggest 
that pain relief after PVP is immediate, is sustained for at least a year and is 
significantly greater than achieved with conservative treatment. A well-designed 
double-blinded randomised controlled trial using the correct indications and 
strict inclusion criteria comparing PVP for long-standing OVCFs to a placebo 
treatment is however still lacking, but seems feasible and should be performed 
in the near future. 
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Samenvatting, Conclusies & 
Toekomstperspectieven 
Samenvatting 
In de algeme ne inleiding in Hoofdstuk 1 van dit proefschrift werd een overzicht 
gegeven van de historie van de PVP (percutane vertebroplastiek) procedure, de 
indicaties, de uitkomsten en de complicaties. 
In Hoofdstuk 2, werd de invloed van het pre-procedureel intravertebraal 
beenmergoedeem (BMO) op de post-procedurele pijnreductie bij patienten 
behandeld met een 'single-level' PVP voor osteoporotische vertebrale compressie 
fracturen (OVCFs) van oudere datum, bestudeerd. Intravertebraal BMO is 
aanwezig in subacute en chronische pijnlijke OVCFs als gevolg van een door 
osteoporose veranderde consolidatie cascade van de compressiefractuur. 
In de meeste klinieken is intravertebraal BMO een van de criteria voor de 
indicatiestelling voor een PVP. Tot op heden is BMO in de literatuur alleen 
nog bestudeerd met semikwantitatieve (indirecte) scoringssystemen en (nog) 
niet door gebruik te maken van een kwantitatieve volumetrische analyse. In de 
studie beschreven in dit hoofdstuk werden 25 patienten (4 mannen, 21 vrouwen, 
gemiddelde leeftijd 72.0 (SD 7.7) jaar met een 'single level' OVCF, met een 
gemiddelde tijd tussen het begin van symptomen tot het ondergaan van een PVP 
procedure van 5.7 maanden (SD 2.6), ge!ncludeerd in een prospectieve studie. 
Alle patienten werden gediagnosticeerd met een pre-operatief conventioneel 
r0ntgenonderzoek (zowel AP als laterale opname van de wervelkolom) en een 
MR-scan met vetsuppressie, T2 Short Tau Inversion-Recovery (STIR), van de 
gehele wervelkolom teneinde intravertebral BMO met sagittale reconstructies 
met een 5 millimeter coupe dikte te visualiseren. Volumetrische analyse van het 
intravertebrale BMO werd vervolgens door twee onafhankelijke beoordelaars 
d.m.v. een visuele drempel bepaald. Ged urende een follow-up periode van 1 jaar, 
werd de Pain Intensity Numerical Scale (Pl-NRS) afgenomen bij alle patienten. 
In een multivariate repeated measures a nalyse, werd geen associatie gevonden 
tussen het volumepercentage BMO (van 10% tot 70%) en post-procedurele rugpijn 
(0.04 per 10% vertebra volume, 95% CI: -0.18-0.26, p=O. 711). Concluderend lijkt 
er geen relatie te bestaan tussen de hoeveelheid BMO op de pre-procedurele MR-
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scan, en de post-procedurele vermindering in rugpijn in het eerste jaar na een 
PVP procedure bij patienten met 'single level' chronische OVCFs. 
Hoofdstuk 3 beschrijft een retrospectieve studie ter bepaling van de prevalentie 
van onverwachte maligniteiten in botbiopten van patienten die een PVP 
procedure ondergaan voor een veronderstelde OVCFs. De meeste VCFs hebben 
een osteoporotische etiologie, daarnaast komt in deze oudere patientenpopulatie 
een varieteit aan maligniteiten zoals multipele myeloom of gemetastaseerde 
ziekte aan het licht. Het verrichten van een botbiopsie uit het wervellichaam 
via de PVP naald, kan een nog onbekende maligne bottumor of metastasen 
aan het licht brengen bij patienten zonder klinische symptomen en normale 
laboratoriu muitslagen. Daarnaastis kennisomtrentde aard van deonderliggende 
pathologie die geleid heeft tot de wervelinzakking, belangrijk voor zowel de 
prognose, het beoordelen van het effect van therapie als voor de lange-termijn 
behandeling van de individuele patient. De histologie van de botbiopten in dit 
cohort van 78 patienten (gemiddelde leeftijd 73 jaar), liet bij 3 patienten (3.8% 
van alle botbiopten), een eerder ongediagnosticeerde maiigniteit zien, waarvan 
2x een multipele myeloom stadium Ila en 1x een chondrosarcoom stadium I. Het 
routinematig verkrijgen van een botbiopt uit het wervellichaam tijdens elke PVP 
procedure, is daarom aanbevolen. 
In Hoofdstuk 4 werd een prospectieve studie van PVP bij patienten met 
hardnekkige type-II OVCFs (gedurende minimaal 8 weken niet succesvol 
conservatief behandeld), beschreven. Hierin werden kwantitatieve klinische 
en radiologische resultaten, gedurende een follow-up periode van 1 tot 3 jaar, 
bestudeerd. Daarnaast werd de kwaliteit van leven (QoL) geanalyseerd met een 
'Pain Intensity Numerical Rating Scale' (PI-NRS, 0 to 10), de 'Short-Form-36 
(SF-36) QoL' vragenlijst en anamnese gegevens. Tijdens de follow-up periode 
werd een directe, en blijvende afname van de gemiddelde en ergste rugpijn 
gevonden na een follow-up van zeven dagen en na 36 maanden postoperatief. 
Tevens werd een significante en klinisch relevante toename van de SF-36 score 
op zes van de acht SF-36 domeinen en de beide 'summary SF-36 scores' gevonden. 
Dit laatste betekent een algehele toename in de QoL in de perceptie van de 
patient. Samenvattend bestaat er een blijvende pijnverlichting en een algehele 
verbetering in zowel de fysieke als psychische gezondheid in de perceptie van 
de patient gedurende een follow-up periode van 3 jaar na PVP voor chronische 
OVCFs. 
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Hoofdstuk 5, beschrijft de invloed van cement viscositeit op de kans op cement 
lekkage. De viscositeit van het cement bleek significa nt geassocieerd te zijn met 
de kans op cement lekkage. Wanneer cement met een lage viscositeit gebruikt 
werd, bleek er sprake te zijn van een bijna drie-voudige kans op cement lekkage in 
vergelijking met het gebruik van cement met een medium viscositeit. De klinische 
160 resultaten van PVP en and ere procedures kunnen, zoals beschreven in Hoofdstuk 
4 (PI-NRS en SF-36 vragenlijsten), betrouwbaar worden geobjectiveerd door 
gebruik te maken van een van de vele in de literatuur beschreven gevalideerde 
vragenlijsten, die de afgelopen jaren zijn ontwikkeld. Wanneer men echter het 
complicatiepercentage bij PVP wil onderzoeken, waarbij de meest voorkomende 
complicatie cement lekkage is, blijkt er geen classificatiesysteem voorhanden 
te zijn waarmee de klinische consequenties van cement lekkage betrouwbaar 
kunnen worden geobjectiveerd. Cement lekkages worden geclassificeerd volgens 
het classificatiesysteem van Yeom et al. (2003), waarin cement lekkages worden 
onderverdeeld in Basivertebraal (B), Segmentaal (8) en Corticaal (C). Dit 
classificatiesysteem geeft ech ter geen informatie over de anatomische locatie 
en het volume van de cement lekkage en lijkt hierdoor klinische releva ntie te 
missen. 
In Hoofdstuk 6 is een nieuw classificatiesysteem ontwikkeld voor de Evaluatie 
van eXtra vertebrale cement lekkage bij PVP, gebaseerd op de Anatomie en 
het volume van de lekkage door gebruik te maken van CT-scan analyse (ofwel 
het EXACT-classificatiesysteem). Dit nieuwe classificatiesysteem combineert 
informatie betreffende de spatiele distributie (anterior (A.x.x.), medial (B.x.x) 
or posterior (C.x.x.)), de anatomische structuren (venous system (x.l.x.), cortical 
defects (x.2.x.) van de lekkage, de specifieke locaties (e.g. vein or discus) en het 
cement lekkage volume (x.x.0.5cc). Door de combjnatie van de anatomische 
beschrijving en de spatiele classificatie van de lekkage, is een meer valide 
registratie van cement lekkages mogelijk. In deze studie werden de direct 
postoperatieve CT-data van 106 vertebra van 53 patienten behandeld met PVP 
geanalyseerd door drie onafhankelijke beoordelaars volgens zowel het bekende 
classificatiesysteem van Yeom et al. als het nieuwe EXACT classificatiesysteem. 
De inter-observer variabiliteit was vergelijkbaar t ussen het classificatiesysteem 
van Yeom et al. (0.97, p<O.OOl) en het EXACT classificatiesysteem (0.94, 
p<O.OOl). Deze s tudie heeft laten zien dat het EXACT classificatiesysteem een 
logisch, accuraat en reproduceerbaar classificatiesysteem voor cement lekkages 
is en heeft daarmee een duidelijke meerwaarde voor wetenschappelijk onderzoek 
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naar de PVP procedure en de verschillende types cement die gebruik t worden bij 
PVP en heeft daarmee ook een verwachte grotere klinische waarde. 
In Hoofdstuk 7 werd tenslotte een review gegeven van het wetenschappelijke 
bewijs over de uitkomsten van een PVP procedure versus conservatieve 
behandeling voor een OVCF. Sinds de introductie van de PVP procedure in 1987, 
zij n meer dan 600 klinische artikelen in de literatuur verschenen. De meeste 
studies beschrijven een aanzienlijke pijnverlichting en verbetering van de 
kwaliteit van leven, wat voornamelijk gebaseerd is op resultaten van onderzoek 
zonder controle groep (i. e. geen PVP) met bovendien een grote varieteit 
aan inclusie- en exclusie criteria. In 2009 werden twee gerandomiseerde 
gecontroleerde trials gepubliceerd in het prestigieuze New England Journal of 
Medicine (NEJM), welke ertoe hebben geleid da t medici over de hele wereld de 
waarde van PVP boven conservatieve behandeling van OVCFs in twijfel trokken. 
Echter, ondanks publicatie in de NEJM bestonden er ook methodologische 
problemen in deze studies. In het review beschreven in dit hoofdstuk, werden de 
belangrijkste klinische ar tikelen beoordeeld op "level of evidence." Na meer dan 
20 jaar na de introductie van PVP, blijven er veel belangrijke vragen betreffende 
het mechanisme en de effectiviteit van de procedure nog onbeantwoord. 




• Het percentage van het wervellichaam gevuld met BMO, gezien op een 
pre-PVP MR-scan, heeft geen voorspellende waarde voor de uitkomst 
van een PVP voor pijnlijke OVCFs van oudere datum (> 8 weken). 
• A1hoewel het overgrote deel van de VCFs een osteoporotische etiologie 
kent, blijkt er in 4% van de behandelde patienten een onverwachte 
maligniteit aanwezig te zijn. Dit pleit voor het routinematig uitvoeren 
van een botbiopsie tijdens elke PVP procedure. 
Kwaliteit van )even analyse bij PVP voor de behandeling van OVCFs van 
oudere datum, resulteert in een onmiddellijke, significante en blijvende 
vermindering van rugpijnklachten en een algemene verbetering 
in de perceptie van de pat,ient van zowel de fysieke als de mentale 
gezondheid. 
• De kans op botcement lekkage blijkt significant geassocieerd te zijn met 
de PMMA botcement viscositeit. 
• Hef·. EXACT r.lasRifir.:-1t.ie syr.;t.eem maakL h~t. mogelijk om op logisr.he, 
precieze en reproduceerbare wijze, cement lekkages bij PVP procedures 
te classificeren en heeft hiermee naast klinische waarde, een duidelijke 
plaats in onderzoek naar de PVP procedure en de verschillende typen 
cement die gebruikt worden bij PVP. 
DISCUSSION & SUMMARY 
Toekomstperspectieven 
Onomstotelijk bewijs ten faveure of ten nadele van de effectiviteit van PVP is tot 
op heden niet geleverd. Prospectieve cohort studies ondersteunen de hypothese 
dat het positieve effect van PVP ontleend wordt aan de mechanische effecten 
van het botcement op het wervellichaam. Verschillende recent verschenen 163 
gerandomiseerde (gecontroleerde) trials, hebben enkele antwoorden gegeven op 
de vraag ofPVP superieur is aan het continueren van conservatieve behandeling 
gedurende een langere periode en suggereren dat pijnverlichting na PVP direct 
en blijvend is gedurende ten minste een jaar en dat de pijnverlichting daarbij 
significant groter is dan die verkregen wordt bij conservatieve behandeling. 
Een goed opgezette, dubbel-blinde gerandomiseerde gecontroleerde studie met 
heldere indicaties voor PVP en duidelijk omschreven inclusie- en exclusiecriteria, 
waarin OVCFs van ouder datum afgezet worden tegen een placebobehandeling, 
is vooralsnog echter niet verricht, maar lijkt zeker haalbaar en zou in de nabije 
toekomst uitgevoerd moeten gaan worden. 
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